COVID-19 Evidence Reviews
as of 8/16/22
menu
 
 

Today's Feature

7/28/2022
The CDC updated has added information on the Novavax COVID-19 vaccine with an overview and safety information.



Completed Reviews
 
= living review
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
8/16/22
Iryaningrum MR, Supriyadi R, Lawrensia S, et al. | Indian J Nephrol
Aim: To delineate better the association between diabetes and mortality among patients with CKD and COVID-19.
8/16/22
Desye B | Front Public Health
Aim: To provide a synthesis of evidence on the prevalence of COVID-19 vaccine acceptance and determinate factors among HCWs.
8/16/22
Wang X, Liu Q | Heliyon
Aim: To determine the prevalence of anxiety among Chinese university students during the COVID-19 epidemic.
8/16/22
Qian Z, Zhang Z, Ma H, et al. | Front Immunol
Aim: To assess whether convalescent plasma therapy could offer survival advantages for patients with novel coronavirus disease 2019 (COVID-19).
RECENTLY UPDATED
CANDIDATE THERAPEUTICS
8/15/22
Bryant MC, Spencer LT, Yalcindag A | Pediatr Rheumatol Online J
Aim: To present a case of new-onset AAV following COVID-19 infection in an adolescent patient, and we review the literature of AAV following COVID-19 infection.
8/15/22
Kauhanen L, Wan Mohd Yunus WMA, Lempinen L, et al. | Eur Child Adolesc Psychiatry
Aim: To compare the mental health of children and young people aged 0–24, before and during the COVID-19 pandemic, and identify any changes.
RECENTLY UPDATED
MENTAL HEALTH
8/15/22
Gempeler A, Griswold DP, Rosseau G, et al. | Front Med
Aim: To identify, appraise, and summarize the available evidence on the diagnostic accuracy of chest CT for rapid diagnosis of COVID-19, and discuss important considerations for its use.
8/15/22
Matar RH, Mansour R, Nakanishi H, et al. | J Clin Med
Aim: To provide insight into the clinical characteristics of patients diagnosed with myocarditis following COVID-19 mRNA vaccination.
8/15/22
Shui X, Wang F, Li L, et al. | PLoS One
Aim: To identify a reliable estimate of acceptance rate of COVID-19 vaccine among HCWs in China.
8/15/22
Hu W, Zhu Y, Wu Y, et al. | J Zhejiang Univ Sci B
Aim: To determine whether the COVID-19 pandemic had any adverse effects on female fertility and the pregnancy outcomes of women undergoing ART.
8/15/22
Nag AK, Saltagi AK, Saltagi MZ, et al. | Ann Otol Rhinol Laryngol
Aim: To establish whether a consensus exists regarding optimal management of olfactory dysfunction and to provide insight into the treatment of anosmia in the current climate of increased prevalence secondary to COVID-19. 
8/15/22
Di Fazio N, Morena D, Delogu G, et al. | Int J Environ Res Public Health
Aim: To evaluate the data belonging to the European framework, analyzing the population by age group.
8/15/22
Freitas T, Ibrahim A, Lourenço A, et al. | Hip Int
Aim: To determine whether patients with PFF affected by COVID-19 have a higher risk of postoperative mortality.
8/15/22
Duncan DB, Mackett K, Ali MU, et al. | Clin Biochem
Aim: To assess the diagnostic performance of saliva compared with NPS for COVID-19
8/15/22
Laher Z, Robertson N, Harrad-Hyde F, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the estimated prevalence of moral injury in nursing and care home staff.
8/15/22
Montrucchio G, Balzani E, Lombardo D, et al. | J Clin Med
Aim: To clarify the use of MR-proADM in severe COVID-19 disease.
8/15/22
Yu W, Guo Y, Zhang S, et al. | J Med Virol
Aim: To assess the pooled proportion of non-severe disease and asymptomatic infection among COVID-19 patients infected with Omicron and Delta.
8/15/22
Leal J, Farkas B, Mastikhina L, et al. | Antimicrob Resist Infect Control
Aim: To assess the risk of VRIs to HCWs in the presence of AGMPs, the role respirators versus medical/surgical masks have on reducing that risk, and if the risk to HCWs during AGMPs differed when caring for adult or pediatric patient populations.
8/15/22
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/15/22
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension on the prognosis of COVID-19.
8/12/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on factors that influence the transmission of and immunological response to SARSCoV-2.
8/12/22
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels.
CLINICAL CHARACTERISTICS
8/12/22
Dondi A, Sperti G, Gori D, et al. | Eur J Pediatr
Aim: To determine the type, prevalence, time of onset, and evolution of cutaneous manifestations associated with COVID-19 in newborns, children, and adolescents, after excluding multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
8/12/22
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/12/22
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension and age as well as the use of ACEI/ARB treatment on the outcomes of COVID-19.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/11/22
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/11/22
Vishwajeet V, Krishna H, Ghatak S, et al. | Saudi J Kidney Dis Transpl
Aim: To summarize the renal histopathological findings in COVID-19 from the published case report and case series.
CLINICAL CHARACTERISTICS
8/11/22
Thakur N, Das S, Kumar S, et al. | J Med Virol
Aim: To trace and understand the origin of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through various available literatures and accessible databases.
8/11/22
Franco-Moreno AI, Bustamante-Fermosel A, Manuel Ruiz-Giardin J, et al. | Rev Clin Esp
Aim: To discover the utility of probability models developed for PE in patients with COVID-19 by reviewing the available literature.
8/10/22
Tripathi AK, Pilania RK, Bhatt GC, et al. | Pediatr Nephrol
Aim: To evaluate the incidence of AKI, mortality, and the need for kidney replacement therapy (KRT) in patients with MIS-C.
CLINICAL CHARACTERISTICS
8/10/22
Lim YJ, Khan U, Karpha I, et al. | EJHaem
Aim: To quantify the clinical outcomes of HCT recipients with COVID?19, as well as a comprehensive subgroup analysis to determine clinical factors associated with adverse outcomes.
CANDIDATE THERAPEUTICS
8/10/22
Donovan MR, Miglani A, Lal D, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe factors associated with IFS in patients with COVID?19.
CLINICAL CHARACTERISTICS
8/10/22
Brooks D, Schulman-Rosenbaum R, Griff M, et al. | Endocr Pract
Aim: To describe the management of glucocorticoid-induced hyperglycemia and to summarize available management strategies for dexamethasone-associated hyperglycemia in COVID-19 patients.
CANDIDATE THERAPEUTICS
8/10/22
Tossetta G, Fantone S, Delli Muti N, et al. | J Hypertens
Aim: To understand the potential involvement of SARS-CoV-2 in preeclampsia onset.
CLINICAL CHARACTERISTICS
8/10/22
Holmes Z, Courtney A, Lincoln M, et al. | Skin Health Dis
Aim: To assess rash morphologies associated with COVID?19 and their relationship with disease severity.
CLINICAL CHARACTERISTICS
8/10/22
Kim DK, Park JJ, Yang WJ, et al. | J Korean Med Sci
Aim: To characterize the relationship between ADT and the severity of COVID-19 in patients with prostate cancer.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/10/22
Sharifi A, Akbari Z, Shafie'ei M, et al. | Ophthalmic Plast Reconstr Surg
Aim: To review the evidence on retrobulbar injection of amphotericin B in patients with COVID-19 associated rhino-orbito-cerebral mucormycosis (CAM).
CANDIDATE THERAPEUTICS
8/10/22
Mehrabi Nejad MM, Shobeiri P, Dehghanbanadaki H, et al. | Virol J
Aim: To investigate the efficacy of COVID-19 vaccines based on the vaccine type and etiology as well as the necessity of booster dose in this high-risk population.
INFECTION CONTROL
8/10/22
Garcia-Albeniz X, Del Amo J, Polo R, et al. | Eur J Epidemiol
Aim: To study the effectiveness of HCQ to prevent COVID-19.
INFECTION CONTROL
8/10/22
Mishra P, Parveen R, Bajpai R, et al. | J Prev Med Public Health
Aim: To investigate the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/9/22
Manoharan S, Ying LY | Can J Infect Dis Med Microbiol
Aim: To further understand the clinical benefits of baricitinib in the management of COVID-19 patients.
CANDIDATE THERAPEUTICS
8/9/22
Boro E, Stoll B | Front Public Health
Aim: To analyze the barriers to COVID-19 health products in low-and middle-income countries (LMICs).
INFECTION CONTROL
8/9/22
Sarfraz M, Sarfraz A, Sarfraz Z, et al. | Ann Med Surg
Aim: To identify the contributing factors of confirmed pediatric COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/22
Liu J, Dong J, Yu Y, et al. | Front Public Health
Aim: To assess the effectiveness and safety of corticosteroids in hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
8/9/22
Ding S, Deng S, Zhang Y, et al. | Front Public Health
Aim: To explore front-line nurses' experiences and needs during the COVID-19 pandemic through a qualitative meta-synthesis.
RECENTLY UPDATED
8/9/22
Namavarian A, Eid A, Ziai H, et al. | Laryngoscope
Aim: To identify FNP clinical characteristics and recovery outcomes among patients acutely infected with COVID-19.
CLINICAL CHARACTERISTICS
8/9/22
Yang Z, Wang X, Zhang S, et al. | Front Public Health
Aim: To compare myopia progression in children before the COVID-19 pandemic and during COVID-19 pandemic home quarantine and at the same time explore the risk factors of myopia progression.
RECENTLY UPDATED
8/9/22
Yehualashet DE, Seboka BT, Tesfa GA, et al. | Risk Manag Healthc Policy
Aim: To examine the proportion of COVID-19 vaccine hesitancy and its associated factors among the Ethiopian population. 
INFECTION CONTROL
8/9/22
Gualano MR, Rossi MF, Borrelli I, et al. | Work
Aim: To evaluate the impact of lasting COVID-19 symptoms or disability on the working population upon their return to employment.
LONG COVID
8/9/22
Whear R, Bethel A, Abbott R, et al. | J Clin Epidemiol
Aim: To suggest possible approaches to combatting the impact of the COVID-19 infodemic in-order to prevent research waste in future health emergencies and in everyday research and practice.
RECENTLY UPDATED
8/8/22
Alves EAS, Salazar TCDN, Silvino VO, et al. | Nutr Clin Pract
Aim: To evaluate the association between phase angle and adverse clinical outcomes in hospitalized patients with coronavirus disease-2019 (COVID-19).
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/8/22
Georgakopoulou VE, Gkoufa A, Garmpis N, et al. | Ann Saudi Med
Aim: To review and analyze all reported cases of COVID-19 associated acute pancreatitis, reporting the demographics, clinical characteristics, laboratory and imaging findings, comorbidities and outcomes.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
8/8/22
Wu Y, Zhang Q, Li M, et al. | Front Public Health
Aim: To conduct a systematic review of the global experiences of community responses to the COVID-19 epidemic.
INFECTION CONTROL
8/8/22
Martinez-Reviejo R, Tejada S, Adebanjo GAR, et al. | Eur J Intern Med
Aim: To summarize the evidence concerning clinical VZV reactivation following SARS-CoV-2 vaccination.
8/5/22
Mollalign H, Chala D, Beyene D | Infect Drug Resist
Aim: To summarize the clinical features and treatment outcomes of coronavirus and tuberculosis co-infected patients.
CLINICAL CHARACTERISTICS
8/5/22
Pilia E, Belletti A, Fresilli S, et al. | J Thromb Thrombolysis
Aim: To investigate the efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients.
8/5/22
Meshram HS, Kute V, Rane H, et al. | Transpl Infect Dis
Aim: To analyze the humoral and cellular response to standard and booster (additional doses) COVID-19 vaccination in solid organ transplantation (SOT) and the risk factors involved for an impaired response.
RECENTLY UPDATED
8/4/22
Sanaullah AR, Das A, Das A, et al. | Soc Netw Anal Min
Aim: To systematically review, assess, and synthesize state-of-the-art research articles that have used different machine learning and deep learning techniques to detect COVID-19 misinformation.
INFECTION CONTROL
8/4/22
Balai MK, Avasthi RD, Va R, et al. | J Caring Sci
Aim: To find out associated psychological impacts among HCP during COVID-19 pandemic.
MENTAL HEALTH
8/3/22
Aryana IGPS, Daniella D, Paulus IB, et al. | Ann Geriatr Med Res
Aim: To examine the effect of CP in older adults with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/3/22
Turki A, Abbas KS, Makram AM, et al. | Acta Neurol Belg
Aim: To systematically review the clinical picture, laboratory/imaging findings, treatment options, and prognostic factors of FNP in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/3/22
Meyer D, Slone SE, Ogungbe O, et al. | AIDS Behav
Aim: To assess the impacts of the pandemic on service engagement, treatment adherence, and viral suppression.
UPDATED
8/3/22
Khokher W, Malhas SE, Beran A, et al. | J Intensive Care Med
Aim: To evaluate the role of IPVD in COVID-19 patients.
8/2/22
Purja S, Oh S, Kim E | Front Neurol
Aim: To compile studies involving COVID-19 patients with neurological manifestations who have undergone polymerase chain reaction (PCR) testing for SARS-CoV-2 in cerebrospinal fluid (CSF) and reported the patient's anosmia status for identifying neurological aspects of COVID-19 and exploring the COVID-19 infected patients with or without anosmia in relation to their CSF PCR assay results.
CLINICAL CHARACTERISTICS
8/2/22
Huang H, Chen J, Fang S, et al. | Front Neurol
Aim: To investigate the association between previous stroke and the risk of severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
8/2/22
Luo X, Lv M, Zhang X, et al. | J Evid Based Med
Aim: To present a comprehensive picture of the clinical symptoms of COVID-19 using an evidence map.
UPDATED
CLINICAL CHARACTERISTICS
8/2/22
Hong W, White PL, Backx M, et al. | Clin Imaging
Aim: To conduct a systematic review and an individual patient-level image analysis of CT findings of COVID-19-associated pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
8/2/22
Siddiqui S, Arifeen M, Hopgood A, et al. | SN Comput Sci
Aim: To demonstrate the analysis and performance of recently proposed methods based on DL to diagnose COVID-19. 
DIAGNOSTICS
8/2/22
Ahmed I, Mustafaoglu R, Yeldan I, et al. | Arch Phys Med Rehabil
Aim: To qualitatively synthesize and quantitatively evaluate the effect of pulmonary rehabilitation (PR) on dyspnea, lung functions, fatigue, exercise capacity, and quality of life (QoL) in patients with COVID-19.
8/2/22
Cevik A, Onat Koroglu C, Karacam Z, et al. | Clin Nurs Res
Aim: To determine the effects of the Covid-19 pandemic on the prevalence of insomnia, anxiety, and depression symptoms during pregnancy.
UPDATED
MENTAL HEALTH
8/2/22
Alshaikh FS, Godman B, Sindi ON, et al. | PLoS One
Aim: To determine current prevalence of bacterial coinfection and antibiotic prescribing in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/2/22
Li M, Zhu H, Liu Y, et al. | Front Pharmacol
Aim: To comprehensively summarize the efficacy and safety of TCM in the treatment of severe/critical COVID-19 patients by systematically collecting available evidence from RCTs and observational studies.
CANDIDATE THERAPEUTICS
8/2/22
Nourmohammadi H, Dehkordi AH, Adibi A, et al. | 
Aim: To estimate the seroprevalence of COVID-19 in blood donors in the world.
8/1/22
Chou OHI, Mui J, Chung CT, et al. | Clin Res Cardiol
Aim: To investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines.
UPDATED
CLINICAL CHARACTERISTICS
8/1/22
Zuin M, Rigatelli G, Bilato C, et al. | J Cardiovasc Med
Aim: To review the evidence on the prevalence and prognostic implications of coronary artery disease (CAD) in patients infected by the novel coronavirus 2019 (COVID-19) disease.
CLINICAL CHARACTERISTICS
8/1/22
Du Z, Wang S, Bai Y, et al. | Transbound Emerg Dis
Aim: To conduct a systematic review of viral dynamic parameters used in within-host models by calibrating the model to the viral load data measured from upper respiratory specimens.
CLINICAL CHARACTERISTICS
7/29/22
Bhowmik KK, Barek MA, Aziz MA, et al. | Health Sci Rep
Aim: To highlight the correlation of numerous biomarkers, including D?dimers, CRP, serum ferritin, lactate dehydrogenase (LDH), random blood sugar (RBS), absolute neutrophil count (ANC), neutrophil to lymphocyte ratio (NLR), serum creatinine, and hemoglobin with the severity of COVID?19 patients in Bangladesh and how their values change based on the intensity of the illness.
CLINICAL CHARACTERISTICS
7/29/22
Sah SK, Shariff A, Pathakamuri N, et al. | PLoS One
Aim: To find the prevalence of fungal secondary infections among COVID-19 patients and patient outcomes in terms of recovery or all-cause mortality following antifungal therapy (AFT) in such patients.
UPDATED
CLINICAL CHARACTERISTICS
7/29/22
Balaouras G, Eusebi P, Kostoulas P | PLoS One
Aim: To collect and meta-analyze available studies on the relationship between SARS-CoV-2 infection and different blood groups, as well as Rhesus state. 
CLINICAL CHARACTERISTICS
7/29/22
Bailly M, Pélissier L, Coudeyre E, et al. | Int J Environ Res Public Health
Aim: To systematically review the effects of physical activity programs in the recovery of post-COVID-19 patients. 
UPDATED
LONG COVID
7/29/22
Hayat U, Ashfaq MZ, Johnson L, et al. | Kans J Med
Aim: To determine the clinical outcomes of COVID-19 among MAFLD patients compared to the non-MAFLD group.
CLINICAL CHARACTERISTICS
7/29/22
Zewdie A, Mose A, Sahle T, et al. | SAGE Open Med
Aim: To assess predictive ability and identify the most frequently related construct of the model to COVID-19 preventive behavior.
INFECTION CONTROL
7/28/22
Anand S, Cao E, Kimura R, et al. | Pathog Glob Health
Aim: To evaluate Asian American COVID-19 healthcare-related behaviors and knowledge.
INFECTION CONTROL
7/28/22
Hung KC, Huang YT, Chang YJ, et al. | Diagnostics
Aim: To examine the association of the F/A ratio with prognostic outcomes among patients contracting COVID-19.
UPDATED
DIAGNOSTICS
7/28/22
Zakariaee SS, Salmanipour H, Naderi N, et al. | Clin Transl Imaging
Aim: To evaluate the association of CT-SS with mortality of COVID-19 patients using systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
7/28/22
Hung KC, Ko CC, Wang LK, et al. | Diagnostics
Aim: To evaluate the prognostic value of PNI for predicting the severity and mortality in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/28/22
Santos AP, Gonçalves LC, Oliveira ACC, et al. | Antibiotics
Aim: To assess the prevalence of co-infection in patients admitted to ICUs with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
7/28/22
Arias M, Oliveros H, Lechtig S, et al. | Pharmaceuticals
Aim: To reevaluate the available evidence of the use of biologics as treatment candidates for the treatment of severe and advanced COVID-19 disease
UPDATED
CANDIDATE THERAPEUTICS
7/28/22
Kim J, Sung H, Lee H, et al. | Viruses
Aim: To evaluate and compare the available evidence on the real-world diagnostic utility of RATs for detecting variants at the point of care.
DIAGNOSTICS
7/28/22
Palomo-Toucedo IC, Lopez-Sanchez MJ, Reina-Bueno M, et al. | Int J Environ Res Public Health
Aim: To determine the most frequent dermatological signs, in the lower limbs, produced by SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/28/22
Wangsan K, Sapbamrer R, Sirikul W, et al. | Int J Environ Res Public Health
Aim: To discern the effects of the N95 respirator by assessing the oxygen and carbon dioxide changes in both high- and low-to-moderate-intensity physical activities in a healthy population.
INFECTION CONTROL
7/28/22
Komariah M, Amirah S, Faisal EG, et al. | Healthcare
Aim: To evaluate the efficacy of iCBT for depression and anxiety among the global population during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/28/22
Bücke P, Hellstern V, Cimpoca A, et al. | J Clin Med
Aim: To review the current evidence supporting the use of EVT for SVT on the basis of case presentations, with a focus on patient selection, treatment strategies and the effects of the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
7/28/22
Galanis P, Vraka I, Katsiroumpa A, et al.  | Vaccines
Aim: To investigate acceptance of the first COVID-19 booster dose and its associated factors among fully vaccinated individuals.
INFECTION CONTROL
7/28/22
Lekagul A, Piancharoen P, Chattong A, et al. | BMJ Open
Aim: To assess interventions and their effectiveness in mitigating psychological consequences from pandemic.
MENTAL HEALTH
7/28/22
Nazia N, Butt ZA, Bedard ML, et al. | Int J Environ Res Public Health
Aim: To review the methodological approaches used to identify the spatial and spatiotemporal variations of COVID-19 and the socioeconomic, demographic and climatic drivers of such variations.
INFECTION CONTROL
7/28/22
Shang W, Kang L, Cao G, et al. | Vaccines
Aim: To assess the percentage of asymptomatic infections among SARS-CoV-2 Omicron variant-positive individuals detected by gene sequencing or specific polymerase chain reaction (PCR).
DIAGNOSTICS
7/28/22
Rabaan AA, Bakhrebah MA, Mutair AA, et al. | Vaccines
Aim: To establish the comparison of health complication noted in vaccinated and non-vaccinated individuals (COVID-19 infected patients) to identify the association between vaccination and the multiorgan failure based on the data obtained from case studies, research articles, clinical trials/Cohort based studies and review articles published between 2020-2022. 
CLINICAL CHARACTERISTICS
7/28/22
Spencer N, Markham W, Johnson S, et al. | Vaccines
Aim: To address the existing gap in the body of evidence and assess the impact of the COVID-19 pandemic on inequities in routine childhood vaccination coverage.
UPDATED
INFECTION CONTROL
7/28/22
Korres G, Kitsos DK, Kaski D, et al. | Brain Sci
Aim: To review the reported prevalence of dizziness and vertigo symptoms as part of COVID-19 disease and discuss the potential neurotropic mechanisms of SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/28/22
Alghamdi NS, Alghamdi SM | Int J Environ Res Public Health
Aim: To summarize the digital technologies used during the COVID-19 pandemic to mitigate the transmission of the COVID-19.
INFECTION CONTROL
7/28/22
Migliorini F, Vaishya R, Eschweiler J, et al. | Medicina
Aim: To provide an account of the role played by vitamins C and D on the onset, progression and severity of COVID-19.
7/27/22
Pitre T, Van Alstine R, Chick G, et al. | CMAJ
Aim: To compare the effectiveness of antiviral drugs for patients with nonsevere COVID-19.
CANDIDATE THERAPEUTICS
7/27/22
Hernandez AV, Piscoya A, Pasupuleti V, et al. | Am J Med
Aim: To assess beneficial and harmful effects of monoclonal antibodies for COVID-19 treatment, and prophylaxis in exposed to SARS-CoV-2.
CANDIDATE THERAPEUTICS
7/27/22
Al-Qudimat AR, Al-Zoubi RM, Elaarag M, et al. | Health Sci Rep
Aim: To offer healthcare workers and non?healthcare workers a comprehensive and up?to?date overview of the currently available information on the severity of the BioNTech?Pfizer vaccine in children and adolescents.
7/27/22
Gaigher JM, Lacerda IB, Dourado MCN | Front Psychiatry
Aim: To better understand the impacts of the COVID-19 pandemic on people with dementia and on their caregivers' mental health.
UPDATED
MENTAL HEALTH
7/27/22
Marando M, Tamburello A, Gianella P, et al. | Caspian J Intern Med
Aim: To evaluate the sensitivity of RT-PCR assays specifically on nasopharyngeal specimens in a population of adults with a clinical suspicion of Coronavirus Disease – 2019 (COVID-19).
DIAGNOSTICS
7/27/22
Federspiel JM, Ramsthaler F, Kettner M, et al. | Rechtsmedizin
Aim: To summarize of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.
7/27/22
Stanford V, Gresh L, Toledo J, et al. | Lancet Reg Health Am
Aim: To characterise the best available evidence (BAE) and assess the extent to which it was used to inform decision-making in 21 Latin American countries.
INFECTION CONTROL
7/27/22
Seyedjavadi SS, Bagheri P, Nasiri MJ, et al. | Front Microbiol
Aim: To evaluate the various aspects such as symptoms, diagnosis, and the most frequent etiological agents of patients with fungal co-infecting COVID-19, treatment, and outcome.
CLINICAL CHARACTERISTICS
7/27/22
Ghahramani S, Kasraei H, Hayati R, et al. | Int J Psychiatry Clin Pract
Aim: To review the evidence on psychological issues experienced by healthcare providers during the COVID-19 pandemic.
MENTAL HEALTH
7/27/22
Nazir M, Asghar S, Rathore MA, et al. | Vacunas
Aim: To give a comprehensive interpretation of menstrual cycle changes after the COVID-19 vaccination.
7/27/22
Patrikar S, Sahu R, Basannar D, et al. | Asia Pac J Public Health
Aim: To summarize serological surveys for SARS-CoV-2 infections carried out in India in general population and health care workers separately with the objective to describe the prevalence of SARS-CoV-2 antibodies.
INFECTION CONTROL
7/27/22
Kulkarni D, Nundy M, McSwiggan E, et al. | J Glob Health
Aim: To explore the association between alcohol consumption in social gatherings and compliance with COVID-19 public health measures.
UPDATED
INFECTION CONTROL
7/27/22
Elhiny R, Al-Jumaili AA, Yawuz MJ | Int J Pharm Pract
Aim: To describe the COVID-19 complications after recovery.
LONG COVID
7/25/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for alternative models of care for managing patients with acute medical conditions outside of emergency or inpatient hospital settings.
7/25/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of oseltamivir on adults and children in a healthcare setting.
7/25/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-acute sequelae of COVID-19 infection.
UPDATED
7/19/22
Noori M, Azizi S, Abbasi Varaki F, et al. | Int Immunopharmacol
Aim: To evaluate the immunogenicity of COVID-19 vaccines in patients with hematological malignancies.
INFECTION CONTROL
7/19/22
Silva BM, Assis LCS, Batista Junior MC, et al. | J Bras Nefrol
Aim: To relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation.
CLINICAL CHARACTERISTICS
7/19/22
Biagianti B, Di Liberto A, Nicolo Edoardo A, et al. | Front Aging Neurosci
Aim: To provide a critical narrative of neuropsychological (NPs) deficits commonly observed after SARS-CoV-2 infection and the tests most suited for detecting such cognitive sequelae depending on illness severity.
UPDATED
MENTAL HEALTH
7/19/22
Kariya A, Krutsri C, Singhatas P, et al. | Int J Surg Open
Aim: To analyze the rate of complicated appendicitis before and during the COVID-19 pandemic.
UPDATED
7/19/22
Mohammadi S, Gouravani M, Salehi MA, et al. | Neuroradiology
Aim: To aggregate the results of the studies which reported imaging of the olfactory system of patients with COVID-19 versus controls.
UPDATED
CLINICAL CHARACTERISTICS
7/19/22
Ku YR, Stager C | Front Psychol
Aim: To update previous empirical work and examine the current evidence for the effectiveness of growth mindset interventions in young adults.
MENTAL HEALTH
7/19/22
Yao W, Dong H, Qi J, et al. | EClinicalMedicine
Aim: To better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19.
CANDIDATE THERAPEUTICS
7/19/22
Hessami K, Sayegh N, Abdolmaleki AS, et al. | J Obstet Gynaecol Res
Aim: To systematically review and summarize the available literature regarding the women's sexual function during COVID-19 pandemic and compare it to pre-pandemic period.
UPDATED
7/18/22
Lin L, Chen Y, Han D, et al. | Front Cardiovasc Med
Aim: To assess the clinical manifestations and outcomes of cardiorenal syndrome or the presence of both cardiac and renal complications in the 2019 coronavirus disease (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/18/22
Lan SH, Hsu CK, Lai CC, et al. | Ann Med
Aim: To assess the usefulness of colchicine in patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
7/18/22
Hernandez AV, Ingemi J 3rd, Sherman M, et al. | Arch Med Sci
Aim: To review the efficacy of hydroxychloroquine as early treatment for COVID-19.
CANDIDATE THERAPEUTICS
7/18/22
Xue C, Liu Z, Xiang H, et al. | Altern Health Ther Med
Aim: To determine the efficacy of interferon (IFN)-based therapy for coronavirus disease 2019 (COVID-19).
UPDATED
CANDIDATE THERAPEUTICS
7/18/22
Cénat JM, Farahi SMMM, Dalexis RD, et al. | J Affect Disord
Aim: To assess the global evolution of mental health problems during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/18/22
El-Qushayri AE, Reda A, Dahy A, et al. | Rev Med Virol
Aim: To provide better insight into the efficacy of mechanical thrombectomy (MT) in managing COVID-19 patients suffering from a stroke.
CLINICAL CHARACTERISTICS
7/18/22
Fang Y, Ji B, Liu Y, et al. | Sci Rep
Aim: To identify the incidence of psychological stress reactions in student populations following a global outbreak and the associated influencing factors.
UPDATED
MENTAL HEALTH
7/18/22
Almulla AF, Supasitthumrong T, Tunvirachaisakul C, et al. | BMC Infect Dis
Aim: To systematically review and meta-analyze the status of the TRYCAT pathway, including the levels of TRP and kynurenine (KYN) and the activity of IDO, as measured by the ratio of KYN/TRP.
CLINICAL CHARACTERISTICS
7/15/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of exercise in helping individuals with COVID-19 to recover, and if post-exertional symptom exacerbation is a risk in long COVID.
LONG COVID
7/14/22
Barberato SH, Bruneto EG, Reis GS, et al. | Arq Bras Cardiol
Aim: To summarize the main echocardiographic findings in patients with Covid-19.
CLINICAL CHARACTERISTICS
7/14/22
Siemieniuk RAC, Bartoszko JJ, Ge L, et al. | BMJ
Aim: To compare the effects of treatments for coronavirus disease 2019 (covid-19).
UPDATED
CANDIDATE THERAPEUTICS
7/14/22
Arayici ME, Kipcak N, Kayacik U, et al. | J Cancer Res Clin Oncol
Aim: To determine both the incidence and ICU (Intensive Care Unit) admission rates and mortality in SARS-CoV-2 infected cancer patients.
UPDATED
CLINICAL CHARACTERISTICS
7/14/22
Tohmasi S, Kabutey NK, Maithel S, et al. | Ann Vasc Surg Brief Rep Innov
Aim: To assess the incidence, risk factors, interventions, and outcomes of acute aortoiliac arterial thrombosis in patients with active SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
7/14/22
 | NSW Health COVID-19 Critical Intelligence Unit
7/14/22
 | NSW Health COVID-19 Critical Intelligence Unit
7/14/22
Baradaran HR, Dehghanbanadaki H, Moradpour F, et al. | Expert Rev Vaccines
Aim: To investigate the pooled effect of COVID-19 mRNA vaccination against SARS-CoV-2 infection and its clinical outcomes.
UPDATED
7/14/22
Rahmati M, Keshvari M, Mirnasuri S, et al. | J Med Virol
Aim: To estimate the risk of global pediatric new-onset T1D, DKA, and severe DKA before and after the COVID-19 pandemic.
7/13/22
Bianchi FP, Stefanizzi P, Di Gioia MC, et al. | Expert Rev Vaccines
Aim: To estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide.
INFECTION CONTROL
7/13/22
Saragih ID, Tarihoran DETAU, Rasool A, et al. | J Nurs Scholarsh
Aim: To update estimates of the prevalence of stigmatization and violence against healthcare workers during the pandemic.
UPDATED
7/13/22
Tunjungputri RN, Tetrasiwi EN, Mulansari NA, et al. | Acta Med Indones
Aim: To provide the most recent update on available evidence on the clinical benefits and risk of oral and parenteral anticoagulants, as well agents with anticoagulant properties, in hospitalized and post-discharge COVID-19 patients.
7/13/22
Dobrijevic Z, Gligorijevic N, Sunderic M, et al. | Rev Med Virol
Aim: To elucidate the potential involvement of genetic variability within HLA loci in the molecular genetics of COVID-19.
7/13/22
Bitar AN, Sulaiman SAS | Curr Med Res Opin
Aim: To evaluate the evidence from clinical trials on the effect of colchicine and corticosteroids against COVID-19.
UPDATED
7/13/22
Tugasworo D, Kurnianto A, Retnaningsih, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To assess and conclude the research-based study systematically to analyze the relationship of MG and COVID-19.
UPDATED
7/12/22
Rangel-Ramírez VV, Macias-Pina KA, Servin-Garrido RR, et al. | Microbiol Res
Aim: To review the scientific literature on antibody IgA immunity to SARS-CoV-2 to determine if IgA could be useful as a diagnostic tool or as a biomarker of severity. 
DIAGNOSTICS
7/12/22
Girma D, Dejene H, Adugna L, et al. | Infect Drug Resist
Aim: To summarize the CFR of COVID-19 and factors contributing to mortality in Ethiopia.
CLINICAL CHARACTERISTICS
7/12/22
Nazari T, Sadeghi F, Izadi A, et al. | PLoS One
Aim: To summarize the studies that have reported CAFIs in Iran.
UPDATED
7/12/22
Raviraj KG, Shobhana SS | Forensic Sci Med
Aim: To determine the findings obtained and inferences drawn from various studies published globally among patients who died due to COVID19.
CANDIDATE THERAPEUTICS
7/12/22
Neville RD, Lakes KD, Hopkins WG, et al. | JAMA Pediatr
Aim: To estimate whether changes in physical activity differed between participant-level, contextual, and methodological moderators during the COVID-19 pandemic.
UPDATED
7/12/22
Skafle I, Nordahl-Hansen A, Quintana DS, et al. | J Med Internet Res
Aim: To synthesize the existing research on misinformation about COVID-19 vaccines spread on social media platforms and its effect.
INFECTION CONTROL
7/12/22
Sawadogo W, Tsegaye M, Gizaw A, et al. | BMJ Nutr Prev Health
Aim: To quantify the association between overweight or obesity and COVID-19-related hospitalisations (including hospital admission, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV)) and death, and to assess the magnitude of the association and the potential dose–response relationships.
UPDATED
CLINICAL CHARACTERISTICS
7/12/22
Bass JR, Poland GA | Vaccine
Aim: To describe SIRVA in the current pandemic, increase clinician awareness, and offer considerations for prevention.
7/12/22
Steeg S, John A, Gunnell DJ, et al. | Br J Psychiatry
Aim: To systematically review evidence on presentations to health services following self-harm during the COVID-19 pandemic.
MENTAL HEALTH
7/12/22
Caironi V, Pitoia F, Trimboli P | Front Endocrinol
Aim: To analyze and summarize data about COVID-19 vaccination and thyroid disease.
CLINICAL CHARACTERISTICS
7/11/22
Carbone L, Trinchillo MG, Di Girolamo R, et al. | Int J Gynaecol Obstet
Aim: To explore perinatal outcomes in SARS-CoV-2 vaccinated pregnant women comparing with unvaccinated counterparts.
7/11/22
Wu HT, Ji CH, Dai RC, et al. | J Integr Med
Aim: To systematically evaluate the methodological quality and quality of evidence in the published systematic reviews and meta-analyses on the use of TCM in the treatment of COVID-19.
7/7/22
Wasim A, Truong J, Bakshi S, et al. | J Ment Health
Aim: To examine mental health literature on prior outbreaks to provide recommendations for developing effective strategies to mitigate the short- and long-term psychological impact of the current pandemic.
MENTAL HEALTH
7/7/22
Dieter C, Brondani LA, Leitao CB, et al. | PLoS One
Aim: To identify genetic polymorphisms that are likely to contribute to COVID-19 pathogenesis.
UPDATED
CLINICAL CHARACTERISTICS
7/7/22
Huldani H, Kamal Abdelbasset W, Abdalkareem Jasim S, et al. | Women Health
Aim: To estimate the pooled prevalence of (intimate partner violence) IPV against pregnant women in the COVID-19 pandemic.
MENTAL HEALTH
7/7/22
D'Ecclesiis O, Gavioli C, Martinoli C, et al. | PLoS One
Aim: To assess the evidence on SARS-CoV2 infection and Covid-19 in relation to deficiency and supplementation of vitamin D.
UPDATED
CLINICAL CHARACTERISTICS
7/6/22
Moura-Coelho N, Cunha JP, Papa-Vettorazzi R, et al. | Acta Ophthalmol
Aim: To examine all the documented cases of acute corneal allograft rejection following SARS-CoV-2 vaccination, and to characterize possible risk factors and graft outcomes after rejection.
7/6/22
Javed A, Karki S, Sami Z, et al. | Biomed Res Int
Aim: To explore the therapeutic potential and safety of using MSC obtained by isolation from health cord tissues in the treatment of patients with COVID-19.
CANDIDATE THERAPEUTICS
7/6/22
Malinga DM, Laher AE, McDowall J, et al. | Curr Urol
Aim: To explore the potential relationship between priapism and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/6/22
Tolksdorf KH, Tischler U, Heinrichs K | BMC Nurs
Aim: To identify factors associated with nurses' turnover intention during the COVID-19 pandemic.
MENTAL HEALTH
7/6/22
Hammoud H, Bendari A, Bendari T, et al. | Cureus
Aim: To provide a comprehensive picture of the SARS-CoV-2 histopathological features of different body organs in postmortem autopsies.
CLINICAL CHARACTERISTICS
7/6/22
Araújo ST, Araújo CT, Silva E Castro R, et al. | Curr Med Chem
Aim: To investigate potential neuroimaging markers of early diagnosis and prognosis of neurologic manifestations in COVID-19.
UPDATED
DIAGNOSTICS
7/6/22
Barmanray RD, Cheuk N, Fourlanos S, et al. | BMJ Open Diabetes Res Care
Aim: To quantify the association between diabetes, hyperglycemia, and outcomes in patients hospitalized for community-acquired pneumonia (CAP) prior to the COVID-19 pandemic.
7/6/22
Qi G, Yuan P, Qi M, et al. | Saf Health Work
Aim: To assess the prevalence and important risk factors of PTSD among medical staff during the COVID-19.
MENTAL HEALTH
7/6/22
Behers BJ, Patrick GA, Jones JM, et al. | Yale J Biol Med
Aim: To perform an in-depth analysis of documented case reports of individuals who developed myocarditis following administration of either the Pfizer or Moderna vaccine.
7/6/22
Pinzon RT, Wijaya VO, Jody AA, et al. | J Infect Public Health
Aim: To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors.
LONG COVID
7/6/22
Tadesse AW, Aychiluhm SB, Mare KU, et al. | Front Public Health
Aim: To estimate the pooled preventive practice and its determinants among the general population.
INFECTION CONTROL
7/6/22
Rayatdoost E, Rahmanian M, Sanie MS, et al. | Yale J Biol Med
Aim: To summarize data regarding the association between sleep and time of vaccination with immunity after vaccination. 
INFECTION CONTROL
7/6/22
Halabchi F, Selk-Ghaffari M, Tazesh B, et al. | Sport Sci Health
Aim: To investigate the role of exercise rehabilitation programs, either in acute or post-acute phase, on physical and psychological outcomes among COVID-19 patients.
UPDATED
7/6/22
Chen CH, Wang CY, Wang YH, et al. | Expert Rev Clin Pharmacol
Aim: To review the evidence on the effect of inhaled corticosteroids (ICS) on the clinical outcomes of patients with coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
7/6/22
Lai CC, Chen WC, Chen CY, et al. | Expert Rev Anti Infect Ther
Aim: To investigate the effectiveness of IVIG in patients with COVID-19.
CANDIDATE THERAPEUTICS
7/5/22
Chao M, Menon C, Elgendi M | Front Med
Aim: To investigate the prevalence of common COVID-19 symptoms in pregnant women and compared the ranked list of symptoms to articles of various sizes.
CLINICAL CHARACTERISTICS
7/5/22
Parvu S, Müller K, Dahdal D, et al. | Eur Rev Med Pharmacol Sci
Aim: To elaborate the possible mechanisms influencing cardiovascular damage, myocardial injury and thromboembolic disease process in particular.
CLINICAL CHARACTERISTICS
7/5/22
Sun XH, Zhang S, Yang Z, et al. | Chin J Integr Med
Aim: To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis.
UPDATED
CANDIDATE THERAPEUTICS
7/5/22
Li P, Guan Y, Zhou S, et al. | Sci Prog
Aim: To review the clinical features and risk factors in patients undergoing maintenance hemodialysis (MHD) who also acquired coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
7/5/22
Zong K, Peng D, Yang H, et al. | Front Immunol
Aim: To determine the factors that contribute to poor antibody response in organ transplant recipients after receiving the 2-dose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.
UPDATED
CLINICAL CHARACTERISTICS
7/1/22
Almeda N, Gomez-Gomez I | Front Psychiatry
Aim: To analyse the changes in smoking consumption during the COVID-19 pandemic through longitudinal studies. 
UPDATED
6/28/22
Kolahchi Z, Khanmirzaei M, Mowla A | J Neurol Sci
Aim: To review the evidence on the incidence of AIS after COVID-19 vaccination.
6/28/22
Yang W, Zhang D, Li Z, et al. | Eur J Cancer
Aim: To assess the factors that predict poor seroconversion comprehensively in order to plan better prevention strategies in this frail population.
6/24/22
Roshdy A, Elsayed AS, Saleh AS | J Intensive Care Med
Aim: To explore the evidence surrounding the use of Airway Pressure Release Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19).
UPDATED
6/24/22
Rozani S, Evangelou K, Schuffert L, et al. | Chirurgie (Heidelb)
Aim: To investigate the reasons for the occurrence of substance dependence and burnout in surgeons and anesthesiologists timelessly and during the COVID-19 pandemic and what improvement measures could help in the clinical practice?
6/24/22
Gioia F, Albasata H, Hosseini-Moghaddam SM | J Fungi
Aim: To evaluate studies reporting concomitant COVID-19 and Pneumocystis jirovecii pneumonia (PJP).
6/24/22
Morello R, Pepe M, Martino L, et al. | Acta Paediatr
Aim: To summarize the cases of myopericarditis after COVID-19 vaccination in pediatric patients and describe its incidence, clinical features, diagnostic pathways, therapeutic strategies and outcome.
6/24/22
Boet S, Etherington C, Ghanmi N, et al. | Diving Hyberb Med
Aim: To review the evidence on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients.
6/24/22
Raquib A, Raquib R, Jamil S, et al. | Front Med
Aim: To review the evidence on the KAP for COVID-19 prevention in Bangladesh.
6/24/22
Santabárbara J, Olaya B, Bueno-Notivol J, et al. | Rev Med Chil
Aim: To review the prevalence of depression in medical students during the COVID-19 pandemic.
6/24/22
Zhang M, Yan X, Shi M, et al.  | Glob Health Res Policy
Aim: To reviewe the safety and efficiency of stem cell therapy in COVID-19 cases.
6/23/22
Kao YS, Lin KT | Radiol Med
Aim: To investigate the predictive power of a CT-based radiomics model in determining COVID-19 severity.
CLINICAL CHARACTERISTICS
6/23/22
Joshi D, Gyanpuri V, Pathak A, et al. | Curr Pain Headache Rep
Aim: To discuss the case-reports having neuropathic pain during and after COVID-19 infection.
CLINICAL CHARACTERISTICS
6/23/22
Li L, Xie H, Wang L, et al. | Chin Med
Aim: To systematically review the clinical efficacy and safety of Chinese herbal medicine (CHM) with and without Western medicine (WM) for different severity of COVID-19.
CANDIDATE THERAPEUTICS
6/23/22
Ji Z, Hu H, Qiang X, et al. | Am J Chin Med
Aim: To compare the efficacy of different traditional Chinese medicine (TCM) therapies for the treatment of coronavirus disease 2019 (COVID-19).
UPDATED
CANDIDATE THERAPEUTICS
6/22/22
Wang Q, Guo S, Wei X, et al. | BMJ Open
Aim: To systematically review the evidence on this topic and provide comprehensive information to guide the control and treatment of TB-COVID coinfection.
UPDATED
INFECTION CONTROL
6/22/22
Yang F, Wen J, Huang N, | Eur Psychiatry
Aim: To estimate the worldwide prevalence of posttraumatic stress disorder (PTSD) in children due to the COVID-19 pandemic, as well as to identify protective or risk factors contributing to child PTSD.
MENTAL HEALTH
6/21/22
Susanna D, Pratiwi D, Purnama SG | F1000Res
Aim: To examine the variations in COVID-19 diagnostic testing and clinical characteristics across various studies.
DIAGNOSTICS
6/21/22
Singh R, Rathore SS, Khan H, et al. | Front Endocrinol
Aim: To estimate the association of obesity with the severity and mortality in coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
6/21/22
Qin J, Wang G, Han D | Int J Infect Dis
Aim: To determine the efficacy of therapeutic plasma exchange (TPE) on mortality in patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/21/22
Khanal R, Raj Bhattarai S, Basnet K, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the cardiac implications of COVID-19, both in terms of cardiac factors predisposing to the disease and cardiac complications of the disease.
UPDATED
CLINICAL CHARACTERISTICS
6/21/22
Levy M, Lestrade V, Said C, et al. | Front Pediatr
Aim: To synthesize knowledge describing the impact of social distancing measures (SDM) during the first wave of the COVID-19 pandemic on acute illness in children.
UPDATED
INFECTION CONTROL
6/21/22
Batu ED, Sener S, Ozen S | Semin Arthritis Rheum
Aim: To present a detailed analysis of COVID-19 associated pediatric vasculitis.
CLINICAL CHARACTERISTICS
6/21/22
Alemayehu A, Demissie A, Yusuf M, et al. | Health Serv Res Manag Epidemiol
Aim: To pool the prevalence of COVID-19 vaccine acceptance and identify its determinants in East Africa.
UPDATED
INFECTION CONTROL
6/21/22
Fattahi H, Seproo FG, Fattahi A | BMC Public Health
Aim: To identify factors affecting the preventive behaviors during the covid-19 pandemic.
INFECTION CONTROL
6/21/22
Li Y, Xiao P, Liu N, et al. | Front Pharmacol
Aim: To integrate the existing evidence to evaluate the efficacy and safety of LQ paired with western medicine in the treatment of patients with COVID-19.
CANDIDATE THERAPEUTICS
6/21/22
Anakpo G, Mishi S | Hum Vaccin Immunother
Aim: To review the measurement of COVID-19 vaccine hesitancy, key determinants and evidence-based strategies to prevent COVID-19 vaccine hesitancy.
INFECTION CONTROL
6/21/22
Tan RSJ, Ng KT, Xin CE, et al. | J Cardiothorac Vasc Anesth
Aim: To evaluate the use of high-dose versus low- dose corticosteroids on the mortality rate of COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
6/21/22
Sadeghi S, Kalantari Y, Shokri S, et al. | J Clin Virol
Aim: To collect all the data about immunogenicity, efficacy, and safety of available COVID-19 vaccines to guide health care workers and families on vaccinating the younger population (2 – 21 years old).
UPDATED
INFECTION CONTROL
6/21/22
Li L, Wang F, Shui X, et al. | PLoS One
Aim: To evaluate the pooled estimated level of knowledge, attitudes, and practices (KAP) about COVID-19 among college students in China.
UPDATED
6/21/22
Idehen JB, Kazi U, Quainoo-Acquah JA, et al. | Cureus
Aim: To determine the patterns of neuropsychiatric manifestations of COVID-19, discussing the frequency and its impact on pre-existing psychiatric disorders.
CLINICAL CHARACTERISTICS
6/21/22
Almas T, Malik J, Alsubai AK, et al.  | Ann Med Surg
Aim: To estimate the prevalence of persisting COVID-19 signs and symptoms after recovery.
CLINICAL CHARACTERISTICS
6/21/22
Ramzi ZS, Fatah PW, Dalvandi A | Front Pyschol
Aim: To estimate the overall prevalence of WPV against HCWs.
6/21/22
Molina-Carballo A, Palacios-López R, Jerez-Calero A, et al. | Curr Issues Mol Biol
Aim: To analyze the knowledge and evidence that exists after the use of melatonin in the treatment of SARS-CoV-2 infection.
CANDIDATE THERAPEUTICS
6/21/22
Ngangue P, Pilabré AH, Barro A, et al. | J Public Health Afr
Aim: To identify and understand the significance of population attitudes toward COVID-19 vaccines in Africa.
INFECTION CONTROL
6/21/22
Schoberer D, Osmancevic S, Reiter L, et al. | Public Health Pract
Aim: To assess the effectiveness of PPE in terms of how well it protected HCWs from COVID-19 infections as well as the side effects experienced by HCWs who used PPE in clinical settings.
INFECTION CONTROL
6/21/22
Lee JX, Chieng WK, Abdul Jalal MI, et al. | Front Med
Aim: To determine the role of serum ferritin in predicting outcomes of COVID-19 infection among patients with SCD.
UPDATED
CLINICAL CHARACTERISTICS
6/21/22
Hirsch C, Park YS, Piechotta V, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19.
INFECTION CONTROL
6/21/22
Ishak A, Mehendale M, Mahmoud AlRawashdeh M, et al. | Gene
Aim: To evaluate the correlation between variability in the host genetics and the severity and susceptibility towards COVID-19.
CLINICAL CHARACTERISTICS
6/21/22
Antonini M, Hinwood M, Paolucci F, et al. | World J Surg
Aim: To investigate changes in the epidemiology of major trauma presentations during the implementation of movement restriction measures to manage the first wave of the SARS-CoV-2 (COVID-19) pandemic.
UPDATED
6/21/22
Sanders I, Stather P, Sivagangan P, et al. | Cureus
Aim: To review our understanding of the incidence, management, and outcomes of patients with COVID-19 who develop thrombotic complications, to reduce direct mortality.
CLINICAL CHARACTERISTICS
6/17/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the current and emerging patient safety issues arising from the COVID-19 pandemic.
6/17/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on seasonal influenza prophylaxis in healthcare and aged care settings.
6/17/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for rapid access models of care for respiratory illnesses, especially during winter seasons, in emergency departments.
6/16/22
Pasquini Neto R, Mazzo FAT, Vieira FA, et al. | Rev Paul Pediatr
Aim: To evaluate the coronavirus disease 2019 (COVID-19) cutaneous manifestations described in pediatric patients and discuss their relevance for early diagnosis.
MENTAL HEALTH
6/16/22
Seid AA, Woday Tadesse A, Hasen AA | BMJ Open
Aim: To determine the severity and mortality of COVID-19 among people with different types of disabilities.
UPDATED
CLINICAL CHARACTERISTICS
6/16/22
Chun HR, Cheon E, Hwang JE | BMJ Open
Aim: To examine changed smoking behaviours, cessation intentions and associated psychological states among smokers during the COVID-19 pandemic.
6/15/22
Cao B, Jing X, Liu Y, et al. | J Thorac Dis
Aim: To summarize the available data on the association between the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical parameters and coagulation parameter.
CANDIDATE THERAPEUTICS
6/15/22
Cremades-Martínez P, Parker LA, Chilet-Rosell E, et al. | Microbiol Spectr
Aim: To review strategies for identifying SARS-CoV-2 infection before the availability of molecular test results, and to assess the reporting quality of the studies identified through the application of the STARD guideline.
CLINICAL CHARACTERISTICS
6/15/22
Shafiee A, Teymouri Athar MM, Kohandel Gargari O, et al. | Virol J
Aim: To evaluate the efficacy of ivermectin for COVID-19 patients based on current peer-reviewed RCTs and to address disputes over the existing evidence.
CLINICAL CHARACTERISTICS
6/15/22
Tao K, Tzou PL, Kosakovsky Pond SL, et al. | Microbiol Spectr
Aim: To determine the extent to which Omicron variants reduced MAb susceptibility.
INFECTION CONTROL
6/15/22
Hatami H, Deravi N, Danaei B, et al. | Int J Methods Psychiatr Res
Aim: To investigate the effectiveness of telephone-delivered services for psychological disorders in the COVID-19 pandemic.
6/14/22
Wright T, Mughal F, Babatunde OO, et al. | Bull World Health Organ
Aim: To provide a comprehensive overview and meta-analysis of the prevalence of burnout among primary health-care professionals in low- and middle-income countries.
MENTAL HEALTH
6/14/22
Meng X, Zhu K, Wang J, et al. | Am J Otolaryngol
Aim: To outline the current knowledge regarding the effects of maternal SARS-CoV-2 infection during pregnancy on newborn hearing.
CLINICAL CHARACTERISTICS
6/14/22
Cao B, Jing X, Liu Y, et al. | J Thorac Dis
Aim: To summarize the available data on the association between the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical parameters and coagulation parameter.
INFECTION CONTROL
6/14/22
Messova A, Pivina L, Muzdubayeva Z et al. | J Emerg Nurse
Aim: To review the evidence on the pathophysiology, symptoms, and treatment of COVID-19-mediated immunoglobulin A vasculitis.
6/14/22
Shobhana SS, Raviraj KG | Egypt J Forensic Sci
Aim: To note the global trends of suicidal ideation, self-harm, and suicidal thoughts amidst the pandemic.
CLINICAL CHARACTERISTICS
6/14/22
Shoar S, Prada-Ruiz ACC, Patarroyo-Aponte G, et al. | Clin Med Insights Circ Respir Pulm Med
Aim: To summarize scarce data in the literature on the development of immune response following vaccination against SARS-CoV-2 and factors associated with a weaker immunity.
MENTAL HEALTH
6/14/22
Kramer A, Prinz C, Fichtner F, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of systemic JAK inhibitors plus standard of care compared to standard of care alone (plus/minus placebo) on clinical outcomes in individuals (outpatient or in-hospital) with any severity of COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/14/22
Watanabe A, So M, Iwagami M, et al.  | Respirol
Aim: To investigate the characteristics and time-course of pulmonary sequelae after recovery from COVID-19 through 1-year follow-up.
CLINICAL CHARACTERISTICS
6/14/22
Motwani R, Deshmukh V, Kumar A, et al. | Infez Med
Aim: To review and summarize histopathological and ultrastructural changes in the placental tissue following SARS-CoV-2 infection.
6/14/22
Battaglini D, Premraj L, Huth S, et al. | J Neurosurg Anesthesiol
Aim: To investigate the use of noninvasive multimodal neuromonitoring in critically ill adult patients with COVID-19 infection.
UPDATED
6/14/22
Drumheller K, Fan CW | Sleep Epidemiol
Aim: To determine if screen time affected sleep during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
6/13/22
Alarcon-Braga EA, Hernandez-Bustamante EA, Salazar-Valdivia FE, et al. | Travel Med Infect Dis
Aim: To estimate the prevalence of the intention to vaccinate against COVID-19 in LAC, and to explore how it varies between different age groups.
UPDATED
INFECTION CONTROL
6/13/22
Kirby A, Drummond FJ, Lawlor A, et al. | Support Care Cancer
Aim: To examine the social, psychological, and economic impacts of COVID-19 on cancer patients.
UPDATED
6/13/22
Ma Y, Deng J, Liu Q, et al. | Int J Environ Res Public Health
Aim: To evaluate the long-term consequences of coronavirus disease 2019 (COVID-19) at 6 months and above.
UPDATED
CLINICAL CHARACTERISTICS
6/13/22
Hernández-Díaz Y, Genis-Mendoza AD, Ramos-Méndez MÁ, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the mental health effects of the COVID-19 pandemic on the general population in Mexico.
UPDATED
MENTAL HEALTH
6/13/22
D'Onofrio G, Trotta N, Severo M, et al. | J Clin Med
Aim: To review the evidence and effectiveness of psychological interventions applied during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.
CLINICAL CHARACTERISTICS
6/13/22
Krumbein H, Kümmel LS, Fragkou PC, et al. | Rev Med Virol
Aim: To critically assess the published literature related to community-acquired viral co-infections and COVID-19 and to evaluate the prevalence, most identified co-pathogens, and relevant risk factors.
UPDATED
CLINICAL CHARACTERISTICS
6/13/22
Fleming CA, Fullard A, Croghan S, et al. | J Clin Med
Aim: To review reported surgical practice and peer-reviewed published review recommendations and guidelines relating to RAS during the pandemic.
MENTAL HEALTH
6/13/22
Li M, Wang Q, Shen J | Int J Environ Res Public Health
Aim: To examine the association between PA and mental health during the COVID-19 pandemic in China.
INFECTION CONTROL
6/13/22
Banchelli F, Negro P, Guido M, et al. | J Clin Med
Aim: To investigate the role that ABO blood groups play in susceptibility to SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
6/13/22
Ghoshouni H, Bagherieh S, Parvizinia M, et al. | Int J Clin Pract
Aim: To better understand whether there is a link between COVID-19 vaccination and cardiac Inflammation.
MENTAL HEALTH
6/10/22
Duc TQ, Chi V, Quang PN | Ethics Med Public Health
Aim: To better understand a comprehensive range of the prevalence of depression during the pandemic in Vietnam.
MENTAL HEALTH
6/10/22
Ndayishimiye C, Lopes H, Middleton J | Research Square
Aim: To investigate how digital health technologies (DHTs) evolved to support the PHC sector during COVID-19 and lessons for the future improvement of PHC.
6/10/22
Bhattarai A, Dhakal G, Shah S, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the effect of preexisting asthma on the risk of ICU admission, intubation, and death from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/22
Senderovich H, Vinoraj D, Stever M, et al. | Ther Adv Infect Dis
Aim: To assess the current knowledge of the COVID-19 treatment modalities for the geriatric population.
6/10/22
Mogharab V, Ostovar M, Ruszkowski J, et al. | Global Health
Aim: To compare the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the pandemic.
6/10/22
Aamir Waheed M, Rashid K, Rajab T, et al.  | Saudi Med J
Aim: To compare the mortality associated with the intensity of anticoagulation in patients admitted with covid-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/22
Loo WK, Hasikin K, Suhaimi A, et al. | Front Public Health
Aim: To understand the current trends and progress in mitigation of hospital readmissions due to COVID-19.
6/9/22
Kouhpayeh H, Ansari H | Int Immunopharmacol
Aim: To determine the risk and clinical features of adverse reactions following immunization of the COVID-19.
6/9/22
Bezerra GMF, de Lucena Feitosa ES, Vale Catunda JG, et al. | Stud Health Technol Inform
Aim: To review studies on applied telemedicine during the COVID-19 pandemic and had assess its effects on the delivered care. 
6/9/22
Carle C, Hughes S, Freeman V, et al. | J Cancer Policy
Aim: To review the evidence on the risk for people with cancer to be infected with SARS-CoV-2 compared to people without cancer.
UPDATED
INFECTION CONTROL
6/9/22
Batista DR, Floriano I, Silvinato A, et al. | J Bras Pneumol
Aim: To answer questions related to the use of anticoagulants in the treatment of COVID-19 patients.
CANDIDATE THERAPEUTICS
6/8/22
Zeng N, Zhao YM, Yan W, et al.  | Mol Psychiatry
Aim: To review the evidence on COVID-19 survivors’ health consequences and sequelae for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/8/22
Fei Z, Chen Z, Du X, et al. | Transfus Med Hemother
Aim: To determine the safety and efficacy of IVIG and CP for COVID-19 and the different treatment effects between these two therapeutics to provide references for treating COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/8/22
Ventura CAI, Denton EE, David JA, et al. | Open Access Emerg Med
Aim: To analyze prehospital Emergency Medical Services (EMS) response to the COVID-19 pandemic.
INFECTION CONTROL
6/8/22
Benvari S, Mahmoudi S, Mohammadi M | World J Pediatr
Aim: To evaluate the viral shedding pattern in gastrointestinal specimens of children with COVID-19.
INFECTION CONTROL
6/8/22
Washrawirul C, Triwatcharikorn J, Phannajit J, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination.
6/8/22
Wang K, Wang L, Li M, et al.  | Front Med
Aim: To evaluate the overall effectiveness of current vaccines and the differences between the various vaccines and variants.
INFECTION CONTROL
6/7/22
Aryana IGPS, Setiati S, Paulus IB, et al. | J Nutr Metab
Aim: To investigate physical training on muscle health and QOL in patients with COVID-19.
UPDATED
6/7/22
Shaikh CF, Palmer Kelly E, Paro A, et al. | J Surg Educ
Aim: To summarize current research on burnout among surgical trainees and surgeons during the COVID-19 pandemic.
MENTAL HEALTH
6/7/22
Shafiee A, Teymouri Athar MM, Nassar M, et al. | Diabetes Metab Syndr
Aim: To evaluate the current evidence available to investigate clinical outcomes between patients with type 1 and type 2 diabetes.
UPDATED
CLINICAL CHARACTERISTICS
6/7/22
Salari N, Vepa A, Daneshkhah A, et al. | Public Health
Aim: To assess to what extent COVID-19 clinical trials have considered the impact of race and ethnicity on COVID-19 vaccine safety and efficacy.
UPDATED
INFECTION CONTROL
6/7/22
Ahmed SK, Mohamed MG, Essa RA, et al. | Diabetes Metab Syndr
Aim: To examine the evidence on myocarditis following COVID-19 vaccination, focusing on patient and disease characteristics, as well as investigation and clinical outcome.
UPDATED
INFECTION CONTROL
6/7/22
Sood A, Tran M, Murthy V, et al. | J Clin Rheumatol
Aim: To examine the immunogenicity and safety of SARS-CoV-2 vaccination in patients with RD.
INFECTION CONTROL
6/7/22
Delanerolle G, Zeng Y, Shi JQ, et al. | World J Psychiatry
Aim: To identify and report: (1) MH conditions commonly observed across all 3 pandemics; (2) Impact of MH outcomes across HCPs, patients and the general public associated with all 3 pandemics; and (3) The prevalence of the MH impact and clinical epidemiological significance.
UPDATED
MENTAL HEALTH
6/7/22
Zhi H, Ji X, Zhao Z, et al. | EClinicalMedicine
Aim: To review the evidence on the potential risk factors for impaired diffusing capacity for carbon monoxide (DLCO) in convalescent COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/6/22
Mose A, Wasie A, Shitu S, et al.  | PLoS One
Aim: To estimate the pooled prevalence of COVID-19 vaccine acceptance and its determinants in Ethiopia.
UPDATED
INFECTION CONTROL
6/6/22
Mirzay-Razaz J, Hassanghomi M, Ajami M, et al. | BMC Nutr
Aim: To review effective food hygiene principles and dietary intakes to reinforce the immune system for prevention of corona virus disease 2019 (COVID-19).
6/6/22
Piscoya A, Parra Del Riego A, Cerna-Viacava R, et al. | PLoS One
Aim: To assess benefits and harms of tocilizumab (TCZ), which is an antibody blocking IL-6 receptors, in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
6/6/22
Bello UM, Kannan P, Chutiyami M, et al. | Front Public Health
Aim: To review the evidence on the prevalence of anxiety and depression among the general populace in Africa during the COVID-19 pandemic and examine associated risk factors.
UPDATED
MENTAL HEALTH
6/6/22
Banerjee M, Pal R, Dutta S | Prim Care Diabetes
Aim: To provide a pooled estimate of the risk of developing incident diabetes following hospital discharge or at least 28 days after the COVID-19 diagnosis compared to matched controls or severity matched influenza/ non-COVID-19 acute upper respiratory tract infections (AURI).
CLINICAL CHARACTERISTICS
6/6/22
Azami M, Moradi Y, Moradkhani A, et al. | Eur J Med Res
Aim: To estimate the prevalence of global SARS-CoV-2 serology in different populations and geographical areas.
INFECTION CONTROL
6/6/22
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | ANZ J Surg
Aim: To investigate the occurrence of SARS-CoV-2 transmission from patients to healthcare workers (HCWs) when tracheostomies are performed.
UPDATED
INFECTION CONTROL
6/3/22
Perez-Lopez FR, Lopez-Baena MT, Perez-Roncero G, et al. | Gynecol Endocrinol
Aim: To compare the female sexual function before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Female Sexual Function Index (FSFI).
6/3/22
Park DY, An S, Kaur A, et al. | Clin Cardiol
Aim: To review the evidence on COVID-19 vaccine-associated myocarditis, delineating its demographics and clinical characteristics.
6/2/22
Shin JI, Kim SE, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To assess the susceptibility to and clinical outcomes of COVID-19 in autoimmune inflammatory rheumatic disease (AIRD) and following AIRD drug use.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Okita Y, Morita T, Kumanogoh A | Inflamm Regen
Aim: To review the evidence on the duration of SARS-CoV-2 RNA positivity from several parts of the obdy and clinical characteristics affecting it.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Au WY, Cheung PP | BMJ
Aim: To evaluate the effectiveness of heterologous and homologous covid-19 vaccine regimens with and without boosting in preventing covid-19 related infection, hospital admission, and death.
INFECTION CONTROL
6/2/22
Piechotta V, Mellinghoff SC, Hirsch C, et al. | Blood Cancer J
Aim: To assess clinical efficacy parameters, humoral and cellular immunogenicity and adverse events (AE) following two doses of COVID-19 approved vaccines.
INFECTION CONTROL
6/2/22
Fragkou PC, Palaiodimou L, Stefanou MI, et al. | Ther Adv Neurol Disord
Aim: To review the effects of different dosing regimens of low molecular weight heparin and/or fondaparinux (LMWH/F) on mortality risk as well as the risk of arterial/venous thrombotic events and hemorrhagic complications in confirmed COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Qu W, Wang Z, Engelberg-Cook E, et al. | Stem Cells Transl Med
Aim: To assess the efficacy and adverse events (AE) rates of MSC cell therapy in individuals hospitalized for COVID-19. 
CANDIDATE THERAPEUTICS
6/2/22
Pourasghari H, Tavolinejad H, Soleimanpour S, et al. | Int J Cardiol Heart Vasc
Aim: To compare the rate of AMI admissions and major complication during the pandemic, in comparison with pre-pandemic periods. 
6/2/22
Fakhruddin KS, Samaranayake LP, Buranawat B, et al. | PLoS One
Aim: To review the prevalence, the likely aetiopathogenesis, and the management of oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2).
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Leazer S, Collen J, Alcover K, et al. | Mil Med
Aim: To determine critical care and organ support outcomes of intensive care unit (ICU) COVID-19 patients and whether they varied depending on the completeness of study follow-up or admission time period.
CLINICAL CHARACTERISTICS
6/2/22
Zhou Y, Ge YT, Yang XX, et al. | Front Public Health
Aim: To determine the prevalence of PE elevation, and the relationship between elevated PE and prognosis in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Huntley CC, Patel K, Bil Bushra SE, et al. | ERJ Open Res
Aim: To describe and compare the longitudinal pulmonary function and computed tomography (CT) features of patients recovering from SARS, MERS and COVID-19 during follow-up.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Hawco S, Rolnik DL, Woolner A, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To review the evidence on the relationship between SARS-CoV-2 mitigation measures and perinatal outcomes, with extensive subgroup analysis. 
UPDATED
CLINICAL CHARACTERISTICS
6/1/22
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19).
UPDATED
CLINICAL CHARACTERISTICS
6/1/22
Zhang L, Ma Y, Shi N, et al. | Phytomedicine
Aim: To systematically assemble the evidence on the efficacy and safety of QFPDD combined with Western medicine treatments (WMT) for COVID-19.
6/1/22
Sheerin D, Abhimanyu, Peton N, et al. | iScience
Aim: To identify mechanisms of immunopathogenic interaction between COVID-19 and TB.
CLINICAL CHARACTERISTICS
6/1/22
Curtin M, Richards HL, Fortune DG | Clin Psychol Rev
Aim: To appraise and synthesize studies investigating resilience among HCWs during COVID-19, H1N1, MERS, EBOLA and SARS pandemics.
MENTAL HEALTH
5/31/22
Brümmer LE, Katzenschlager S, McGrath S, et al. | PLoS Med
Aim: To review the accuracy of commercially available Ag-RDTs, further explore the impact of viral load, the presence of symptoms, and the testing procedure on the accuracy of Ag-RDTs.
DIAGNOSTICS
5/31/22
Lemes IR, Smaira FI, Ribeiro WJD, et al. | Br J Sports Med
Aim: To describe acute/postacute COVID-19 presentations in athletes.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Mei Y, Guo X, Chen Z, et al. | Int J Environ Res Public Health
Aim: To quest for the optimal HCW monitoring mechanism and provide practical recommendations for administrators of healthcare facilities, leadership of healthcare systems, as well as policy makers tackling this global issue.
INFECTION CONTROL
5/31/22
Levin AT, Owusu-Boaitey N, Pugh S, et al. | BMJ Glob Health
Aim: To review the evidence on age-specific seroprevalence or IFR for developing countries.
CLINICAL CHARACTERISTICS
5/31/22
Lee ARYB, Wong SY, Tay SH | Vaccines
Aim: To study seroconversion rates and antibody levels post-vaccination in IMID patients.
UPDATED
INFECTION CONTROL
5/31/22
Parmar K, Subramanyam S, Del Rio-Pertuz G, et al. | Vaccines
Aim: To investigate the patient characteristics and provide an overview of the management for patients that develop AEs after vaccination.
5/31/22
Trott M, Driscoll R, Irlado E, et al. | EClinicalMedicine
Aim: To (a) aggregate changes in screen time in adults and children, and (b) report on variables in relation to screen time during the COVID-19 pandemic.
5/31/22
Gopinath S, Ishak A, Dhawan N, et al. | Trop Med Infect Dis
Aim: To assess breakthrough SARS-CoV-2 infections in vaccinated individuals by variant distribution and to identify the common risk associations.
INFECTION CONTROL
5/31/22
Achangwa C, Park H, Ryu S, et al. | Viruses
Aim: To investigate the collateral impact of PHSMs used during the coronavirus disease 2019 (COVID-19) pandemic on the epidemiology of other respiratory viruses, including influenza, parainfluenza, respiratory syncytial virus, rhinovirus, and adenovirus infections.
INFECTION CONTROL
5/31/22
Fernández-Lázaro D, Ortega CD, Sánchez-Serrano N, et al. | Pharmaceutics
Aim: To systematically analyze the evidence of the effect and safety of treatment with CP therapy using randomized controlled trials (RCTs) to confirm the usefulness of this intervention in hospitalized patients with COVID-19. 
UPDATED
CANDIDATE THERAPEUTICS
5/31/22
Dadras O, SeyedAlinaghi S, Karimi A, et al. | Health Sci Rep
Aim: To systematically review the mortality rates in older patients compared to young patients.
5/31/22
Patwary MM, Bardhan M, Haque MZ, et al. | Vaccines
Aim: To assess the acceptance and hesitancy of COVID-19 vaccination rates among HCSs globally and identify the factors predicting vaccine acceptance. 
INFECTION CONTROL
5/31/22
Hosseini B, El Abd A, Ducharme FM | Nutrients
Aim: To evaluate the impact of vitamin D supplementation on COVID-19 related outcomes.
UPDATED
CANDIDATE THERAPEUTICS
5/31/22
Toro-Huamanchumo CJ, Castro-Reyes MM, Peralta V, et al. | Int J Environ Res Public Health
Aim: To assess the efficacy and safety of extracorporeal membrane oxygenation (ECMO) in patients under mechanical ventilation with COVID-19 and severe acute respiratory distress syndrome (ARDS).
5/31/22
Panneer S, Kantamaneni K, Palaniswamy U, et al. | Healthcare
Aim: To explore health, economic and social development issues in a COVID-19 pandemic context and aftermath. 
5/31/22
Degarege A, Naveed Z, Kabayundo J, et al. | Pathogens
Aim: To review the evidence on the risk factors of severe illness, admission to the ICU, and death among COVID-19 patients, and we assessed the sources of heterogeneity and publication bias among the studies.
5/31/22
Cheng H, Peng Z, Si S, et al. | Vaccines
Aim: To assess the immunogenicity and safety of the different combinations of prime–boost vaccinations.
INFECTION CONTROL
5/31/22
Jia Q, Qu Y, Sun H, et al. | Front Psychol
Aim: To assess the pooled prevalence of depression and anxiety among medical students worldwide.
UPDATED
MENTAL HEALTH
5/31/22
Jamiruddin MR, Meghla BA, Islam DZ, et al. | Life
Aim: To explore the different microfluidic-based diagnostics kits and how their amalgamation with the various detection techniques has spearheaded their availability throughout the world.
DIAGNOSTICS
5/31/22
Firouzkouhi M, Abdollahimohammad A, Rezaie-Kheikhaie K, et al. | Health Sci Rev
Aim: To explore nurses' caring experiences in the COVID-19 pandemic.
MENTAL HEALTH
5/31/22
Buitrago-Garcia D, Ipekci AM, Heron L, et al. | PLoS Med
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Anghelescu A, Onose G, Popescu C, et al. | Biomedicines
Aim: To review the evidence on post-SARS-CoV-2 immune-mediated reactions responsible for promoting neurodegeneration.
CLINICAL CHARACTERISTICS
5/31/22
Pogorzelska K, Chlabicz S | Int J Environ Res Public Health
Aim: To review the evidence on the effectiveness of this modality and patient satisfaction with telemedicine.
INFECTION CONTROL
5/31/22
Loader J, Taylor FC, Lampa E, et al. | J Am Heart Assoc
Aim: To assess the extent of bias in that research and reevaluated RAAS inhibitor-COVID-19 associations in studies without critical risk of bias.
UPDATED
5/31/22
Dzinamarira T, Murewanhema G, Chitungo I, et al.  | J Infect Public Health
Aim: To determine the association of HIV/AIDS comorbidity with COVID-19 mortality.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Marin S, Val AM, Peligero MB, et al. | Pharmaceuticals
Aim: To assess and summarise the available literature on the early toxicity of CQ and HCQ alone or in combination with other drugs that have been used to treat COVID-19 in different clinical situations.
UPDATED
CANDIDATE THERAPEUTICS
5/31/22
Wang Y, Xie Y, Hu S, et al. | Front Immunol
Aim: To compare the risk of SARS-CoV-2 infection, severe COVID-19 symptoms, and death of PLWH with those without HIV.
CLINICAL CHARACTERISTICS
5/31/22
Golawski M, Lewandowski P, Jablonska I, et al. | Viruses
Aim: To identify mutations that have been applied to—or could be applied to—SARS-CoV-2 to attenuate it. 
INFECTION CONTROL
5/31/22
Sasidharanpillai S, Ravishankar N | Asian Pac J Cancer Prev
Aim: To assess the pooled proportion of women screened for cervical cancer before and during the COVID-19 pandemic.
5/31/22
Galanis P, Vraka I, Siskou O, et al. | Vaccines
Aim: To evaluate the evidence in the literature regarding the uptake of COVID-19 vaccinations among pregnant women. 
INFECTION CONTROL
5/31/22
Kim TH, Kang JW, Jeon SR, et al. | Front Med
Aim: To identify the overall usage prevalence of TCIM interventions for COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
5/31/22
See KC | Vaccines
Aim: To review the evidence on the effects of vaccination on immunocompromised patients.
INFECTION CONTROL
5/31/22
Oliveira da Silva Kist ML, Hanzen Andrades GR, Drumond Costa CA, et al. | Clin Nutr ESPEN
Aim: To systematically review the literature on the relation between weight excess and the severity of COVID-19 in children and adolescents.
UPDATED
CLINICAL CHARACTERISTICS
5/26/22
Higdon MM, Wahl B, Jones CB, et al.  | Open Forum Infect Dis
Aim: To review COVID-19 vaccine efficacy and effectiveness data against multiple clinical outcomes, for both full and partial immunization courses, by circulating SARS-CoV-2 variants of concern. 
INFECTION CONTROL
5/26/22
Hariyanto TI, Jodhinata C, Halim DA, et al. | Gastroenterol Hepatol Bed Bench
Aim: To provide evidence of the association between viral hepatitis and severe outcomes of COVID-19.
CLINICAL CHARACTERISTICS
5/26/22
Samimisedeh P, Jafari Afshar E, Shafiabadi Hassani N, et al. | J Magn Reson Imaging
Aim: To summarize cardiac MRI findings in COVID-19 vaccine-related myocarditis.
CLINICAL CHARACTERISTICS
5/26/22
Cui X, Zhai Y, Wang S, et al. | Med Sci Monit
Aim: To systemically evaluate the effect of the COVID-19 pandemic on serum vitamin D levels in people under age 18 years. 
5/26/22
Hernández-Vásquez A, Barrenechea-Pulache A, Comandé D, et al. | Evid Based Dent
Aim: To review the evidence regarding the effect of different mouthrinses on the viral load of SARS-CoV-2 in the saliva of infected patients.
INFECTION CONTROL
5/26/22
de Sire A, Andrenelli E, Negrini F, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/26/22
Cascini F, Pantovic A, Al-Ajlouni YA, et al. | EClinicalMedicine
Aim: To synthesize the current evidence regarding the potential role of social media in shaping COVID-19 vaccination attitudes, and to explore its potential for shaping public health interventions to address the issue of vaccine hesitancy.
UPDATED
INFECTION CONTROL
5/25/22
Zeng B, Gao L, Zhou Q, et al. | BMC Med
Aim: To provide a comprehensive overview of the effectiveness profile of COVID-19 vaccines against VOC.
UPDATED
INFECTION CONTROL
5/25/22
Ling RR, Ramanathan K, Sim JJL, et al. | Crit Care
Aim: To characterise changes in mortality over time and elucidate risk factors for poor outcomes in COVID-19 patients receiving ECMO.
UPDATED
CANDIDATE THERAPEUTICS
5/25/22
ElSawi HA, Elborollosy A | Egypt J Intern Med
Aim: To assess post-COVID vaccination immune-mediated adverse events and evaluate its association to specific type of vaccine global wide.
INFECTION CONTROL
5/25/22
Epton T, Ghio D, Ballard LM, et al. | Soc Sci Med
Aim: To determine which interventions and behavior change techniques (BCTs) are effective in promoting adherence to distancing and through which potential mechanisms of action (MOAs).
UPDATED
INFECTION CONTROL
5/25/22
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/25/22
Dadashi M, Dadashi A, Sameni F, et al. | Gene Rep
Aim: To assess the status of patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV.
CLINICAL CHARACTERISTICS
5/25/22
Zhai K, Xu X, Zhang P, et al. | Perfusion
Aim: To evaluate the effect of VV-ECMO in the treatment of patients with COVID-19.
5/24/22
Liana P, Liberty IA, Murti K, et al. | Immunol Res
Aim: To summarize studies on the role of NETs in determining the prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
5/24/22
Panagouli ED, Thirios AC, Psaltopoulou T, et al. | EMBnet
Aim: To evaluate special features and probable correlations between symptoms, laboratory findings, treatment, and outcomes of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
5/24/22
Chen J, Zhang SX, Yin A, et al. | J Glob Health
Aim: To summarize the prevalence of anxiety, depression, distress, insomnia, and PTSD in the adult population during the first year of the COVID pandemic in developing countries.
MENTAL HEALTH
5/24/22
Pacheco JA, Molena KF, Martins CROG, et al. | Bull Natl Res Cent
Aim: To critically assess the clinical evidence on the use of photobiomodulation (PBMT) and antimicrobial photodynamic therapy (aPDT) for the treatment of oral lesions in patients infected with Sars-Cov-2.
CANDIDATE THERAPEUTICS
5/24/22
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/24/22
Lee TC, Murthy S, Del Corpo O, et al. | Clin Microbiol Infect
Aim: To evaluate the role of remdesivir for hospitalized inpatients as a function of oxygen requirements.
CANDIDATE THERAPEUTICS
5/24/22
Barberis N, Cannavò M, Cuzzocrea F, et al. | Clin Neuropsychiatry
Aim: To carry out a comprehensive investigation of suicide risk factors during the current COVID-19 pandemic. 
MENTAL HEALTH
5/24/22
Huang JA, Hartanti IR, Colin MN, et al. | Digit Health
Aim: To review various artificial intelligence-based telemedicine research during the COVID-19 outbreak and proposes a framework for developing telemedicine powered by artificial intelligence to monitor progression in COVID-19 patients during isolation at home.
INFECTION CONTROL
5/24/22
Michailidou D, Stavridou A, Panagouli ED, et al. | EMBnet
Aim: To summarize current evidence on vertical transmission rates, maternal, perinatal and neonatal outcomes and mode of delivery in pregnancies affected by COVID-19.
CLINICAL CHARACTERISTICS
5/24/22
O'Mahoney LL, Highton PJ, Kudlek L, et al. | Diabetes Obes Metab
Aim: To identify, appraise and synthesise available evidence on the impact of the pandemic on glycaemic control in people with diabetes.
UPDATED
5/24/22
Tabatabaeizadeh SA | Eur J Med Res
Aim: To evaluate the effect of zinc supplementation on COVID-19 mortality.
CANDIDATE THERAPEUTICS
5/23/22
Talukder A, Razu SR, Alif SM, et al. | J Multidiscip Healthc
Aim: To evaluate the association between symptoms and severity of disease in adult patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
5/23/22
Lee CJ, Woo W, Kim AY, et al. | J Med Virol
Aim: To provide a comparative meta-analysis and systematic review of the risk and clinical outcomes of COVID-19 infection between fully vaccinated and unvaccinated groups.
CLINICAL CHARACTERISTICS
5/23/22
Kesheh MM, Shavandi S, Haeri Moghaddam N, et al. | Virol J
Aim: To review the evidence on the effectiveness of herbal compounds against coronavirus family, which may have the potential in treating COVID19 infection.
CANDIDATE THERAPEUTICS
5/23/22
Castanares-Zapatero D, Chalon P, Kohn L, et al. | Ann Med
Aim: To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.
LONG COVID
5/23/22
Zuin M, Rigatelli G, Bilato MJ, et al. | Vascular
Aim: To assess prevalence and prognostic implications of pre-existing peripheral artery disease (PAD) in patients infected by the SARS-CoV-2.
CLINICAL CHARACTERISTICS
5/23/22
Kudhail K, Thompson J, Mathews V, et al. | Int J Infect Dis
Aim: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19.
5/23/22
Kim H, Hughes E, Cavanagh A, et al. | PLoS One
Aim: To conduct a mixed methods systematic review on the impacts of the COVID-19 pandemic on the health of people who experience imprisonment.
UPDATED
5/20/22
Keskin AU, Ciragil P, Topkaya AE | Int J Microbiol
Aim: To collect and analyse current evidence on real-world performance based on clinical accuracy of instrument-read rapid antigen diagnostic tests (Ag-IRRDTs) for SARS-CoV-2 identification.
UPDATED
DIAGNOSTICS
5/20/22
Lee KH, Li H, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To describe the clinical and laboratory characteristics of MIS-C.
CLINICAL CHARACTERISTICS
5/20/22
Alvares MA, Ribas BHB, Miranda GB, et al. | Rev Assoc Med Bras
Aim: To correlate 25(OH)D levels with the clinical prognosis of pediatric patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
5/20/22
Javadinia SA, Alizadeh K, Mojadadi MS, et al. | Front Endocrinol
Aim: To assesse the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome, with severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.
INFECTION CONTROL
5/20/22
Alahyari S, Moradi M, Rajaeinejad M, et al. | Expert Rev Hematol
Aim: To comprehensively assess the post-COVID hematologic complications in patients.
CLINICAL CHARACTERISTICS
5/19/22
Ackah M, Ameyaw L, Gazali Salifu M, et al. | PLoS One
Aim: To review the acceptance rate and possible reasons for COVID-19 vaccine non-acceptance/hesitancy amongst HCWs in Africa.
UPDATED
INFECTION CONTROL
5/19/22
Pandey R, Rai D, Tahir MW, et al.  | Arch Med Sci Atheroscler Dis
Aim: To review the evidence on the comorbidities and symptoms of adult patients with coronavirus disease 2019 (COVID-19) to evaluate comorbidities, symptoms, and severity.
CLINICAL CHARACTERISTICS
5/18/22
Lan SH, Lai CC, Chang SP, et al. | Expert Rev Clin Pharmacol
Aim: To investigate the clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19.
CANDIDATE THERAPEUTICS
5/17/22
Sofizan NMFBN, Rahman AFBA, Soon LP, et al. | Egypt J Forensic Sci
Aim: To summarize the autopsy findings related to COVID-19 death.
CLINICAL CHARACTERISTICS
5/17/22
Péterfi A, Mészáros Á, Szarvas Z, et al. | Physiol Int
Aim: To review the evidence on the relationship of comorbidities and mortality due to Coronavirus Disease 2019 (COVID-19) among the elderly population.
CLINICAL CHARACTERISTICS
5/17/22
Mayra ST, Kandiah J, McIntosh CE | Psychol Sch
Aim: To synthesize the existing literature on how COVID?19 impacted K?12 students' eating patterns, physical activity, and sleep in the United States. 
MENTAL HEALTH
5/17/22
Meng X, Wang J, Sun J, et al. | Front Neurol
Aim: To examine whether COVID-19 causes an increased incidence of SSNHL and the clinical characteristics of patients with COVID-19-related SSNHL.
CLINICAL CHARACTERISTICS
5/17/22
Zareei M, Tabanejad Z, Oskouie F, et al. | J Educ Health Promot
Aim: To review the studies on burnout among nurses during the COVID-19 epidemic.
MENTAL HEALTH
5/17/22
Alshammary AF, Alsughayyir JM, Alharbi KK, et al. | Front Med
Aim: To analyze T-cell subsets (CD4/CD8) and IL-10 in severe and fatal cases of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Riccò M, Ranzieri S, Peruzzi S, et al. | Acta Biomed
Aim: To assess available evidence and to explore the reliability of antigenic tests in the management of the SARS-CoV-2 pandemic.
DIAGNOSTICS
5/16/22
Afzal S, Nasir M | J Coll Physicians Surg Pak
Aim: To assess risk factors and case fatality in COVID-19 cases with aspergillosis or mucormycosis.
CLINICAL CHARACTERISTICS
5/16/22
Lee B, Ashcroft T, Agyei-Manu E, et al.  | J Glob Health
Aim: To assess whether the common clinical features of COVID-19 have changed to the point that the criteria used to identify both COVID-19 and influenza in surveillance programs needs to be altered.
CLINICAL CHARACTERISTICS
5/16/22
Mastan S, Hodhody G, Sajid M, et al. | Geriatr Orthop Surg Rehabil
Aim: To assess the early mortality rate of hip fracture patients in the UK, with and without COVID-19 infection.
CLINICAL CHARACTERISTICS
5/16/22
Toro-Huamanchumo CJ, Benites-Meza JK, Mamani-García CS, et al.  | J Clin Med
Aim: To assess the efficacy of colchicine in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
5/16/22
Vaseghi N, Sharifisooraki J, Khodadadi H, et al.  | Mycoses
Aim: To evaluate and estimate the global prevalence of coronavirus-associated C. auris infection (CACa).
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Lv J, Wu H, Xu J, et al. | Infect Dis Poverty
Aim: To pool the evidence on the immunogenicity and safety of heterologous versus homologous prime-boost vaccination schedule.
INFECTION CONTROL
5/16/22
Cho K, Park S, Kim EY, et al. | J Med Virol
Aim: To compare the efficacy of COVID-19 vaccination in patients with solid tumor, hematologic malignancy, autoimmune disease, inflammatory bowel disease, and patients who received transplantation or dialysis.
INFECTION CONTROL
5/16/22
Altobelli E, Angeletti PM, Marzi F, et al. | J Clin Med
Aim: To robustly quantify admission trends of patients with ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI) during the first wave of the pandemic and to characterize on a large basis the risk profile and early prognosis.
CLINICAL CHARACTERISTICS
5/16/22
Landoni G, Belloni O, Russo G, et al. | J Clin Med
Aim: To identify all the literature published and all the currently ongoing trials on volatile anesthetics in COVID-19 patients to enlighten the pros/cons of their role in this setting.
5/16/22
Nappi F, Bellomo F, Avtaar Singh SS | J Clin Med
Aim: To investigate the role of inflammatory pathways, highlighting several culprits including neutrophil extracellular traps (NETs) which have since been extensively investigated.
CLINICAL CHARACTERISTICS
5/16/22
Juneau CE, Pueyo T, Bell M, et al. | Syst Rev
Aim: To provide a comprehensive summary of the evidence on past pandemic controls, with a focus on cost-effectiveness.
5/16/22
Teschke R, Méndez-Sánchez N, Eickhoff A | Int J Mol Sci
Aim: To analyze published reports on conventional drugs and their role in causing liver injury among COVID-19 patients.
5/16/22
Ruvinsky S, Voto C, Roel M, et al. | Front Pediatr
Aim: To describe the clinical course, laboratory findings, epidemiology, treatment, and use of resources of MIS-C in children from LAC.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Santana LADM, Vieira WA, Gonçalo RIC, et al. | J Stomatol Oral Maxillofac Surg
Aim: To better understand the relationship between COVID-19 infection and oral lesions.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Carmassi C, Pacciardi B, Gravina D, et al. | Int J Environ Res Public Health
Aim: To evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients. 
CLINICAL CHARACTERISTICS
5/16/22
Fugazzaro S, Contri A, Esseroukh O, et al. | Int J Environ Res Public Health
Aim: To explore the effectiveness of rehabilitation interventions for adult patients with PACS by reporting the main changes in outcomes after the experimental interventions.
UPDATED
5/16/22
Caini S, Martinoli C, La Vecchia C, et al. | Int J Environ Res Public Health
Aim: To estimate SARS-CoV-2 infections detected in schools comparing positive rates found from screening and contact tracing methods, to compare infectivity and susceptibility of students compared to school staff, and to investigate reasons of between-study heterogeneity.
INFECTION CONTROL
5/16/22
Carvalho S, Coelho CG, Kluwe-Schiavon B, et al. | Int J Environ Res Public Health
Aim: To systematically review the impact of the early stages COVID-19 pandemic on people with pre-existing psychiatric disorders.
MENTAL HEALTH
5/16/22
Dellafiore F, Arrigoni C, Nania T, et al.  | Acta Biomed
Aim: To synthesize the current evidence on the impact of the COVID-19 pandemic on caregivers' mental health.
UPDATED
MENTAL HEALTH
5/16/22
Chen F, Tian Y, Zhang L, et al. | Int J Infect Dis
Aim: To (1) assess the prevalence of pediatric COVID-19 in family clusters; (2) estimate the household secondary attack rate of children in different periods and variants; (3) compare the transmissibility of SARS-CoV-2 in different age groups and explore its potential determinants.
UPDATED
INFECTION CONTROL
5/16/22
Mani A, Ojha V | Ann Vasc Surg
Aim: To systematically review thromboembolic events reported after Covid-19 vaccination.
5/13/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on emerging SARS-CoV-2 variants.
5/12/22
Moneer O, Daly G, Skydel JJ, et al. | BMJ
Aim: To systematically identify, match, and compare treatment effects and study demographics from individual or meta-analysed observational studies and randomized controlled trials (RCTs) evaluating the same covid-19 treatments, comparators, and outcomes.
CANDIDATE THERAPEUTICS
5/12/22
Tavares-Júnior JWL, de Souza ACC, Borges JWP, et al. | Cortex
Aim: To determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).
UPDATED
CLINICAL CHARACTERISTICS
5/12/22
Prasad S, Kalafat E, Blakeway H, et al. | Nat Commun
Aim: To review the effects of COVID-19 vaccination in pregnancy, and on vaccine effectiveness in pregnancy.
UPDATED
INFECTION CONTROL
5/11/22
Chang Y, Bai M, You Q | Biomed Res Int
Aim: To investigate the association between interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/11/22
Jiang L, Tang K, Irfan O, et al. | Curr Pediatr Rep
Aim: To investigate and synthesize evolving evidence on its clinical characteristics, management, and outcomes in pediatric patients.
CLINICAL CHARACTERISTICS
5/11/22
Kolahdouzan K, Chavoshi M, Bayani R, et al. | Int J Radiat Oncol Biol Phys
Aim: To review studies incorporating WLI for the treatment of COVID-19 pneumonia.
UPDATED
CANDIDATE THERAPEUTICS
5/11/22
Verleye A, Wijtvliet V, Abrams S, et al. | Nephrol Dial Transplant
Aim: To compare the antibody response after two-dose mRNA-1273 versus BNT162b2 vaccination in solid organ transplant (SOT) recipients.
UPDATED
INFECTION CONTROL
5/10/22
Weng Y, Yi GY | J Med Virol
Aim: To provide sensible estimates of the mean incubation time of COVID-19 by capitalizing on available estimates reported in the literature and exploring different ways to accommodate heterogeneity involved in the reported studies.
CLINICAL CHARACTERISTICS
5/4/22
 | NSW Health COVID-19 Critical Intelligence Unit
LONG COVID
5/4/22
 | NSW Health COVID-19 Critical Intelligence Unit
5/4/22
 | NSW Health COVID-19 Critical Intelligence Unit
5/2/22
Chow KW, Pham NV, Ibrahim BM, et al. | Dig Dis Sci
Aim: To analyze every published case of AIH and reviewed their characteristic findings, treatment, and outcomes.
INFECTION CONTROL
5/2/22
Rahmani A, Dini G, Leso V, et al. | Med Lav
Aim: To review the evidence on the duration of SARS-CoV-2 shedding and infectivity in the working age population.
INFECTION CONTROL
5/2/22
Umesh A, Pranay K, Pandey RC, et al. | Infection
Aim: To perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms.
5/2/22
Madewell ZJ, Yang Y, Longini IM Jr, | JAMA Netw Open
Aim: To evaluate how reported household SARs changed over time and whether SARs varied by viral variant and index case and contact vaccination status.
INFECTION CONTROL
5/2/22
Doceda MV, Gavriiloglou M, Petit C, et al. | Oral Health Prev Dent
Aim: To evaluate the potential association of COVID-19 infection with oral health.
CLINICAL CHARACTERISTICS
5/2/22
Shahsavarinia K, Rahvar G, Soleimanpour H, et al. | Pak J Med Sci
Aim: To investigate the underlying factors causing pneumothorax, pneumomediastinum, and subcutaneous emphysema in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/2/22
McCosker LK, El-Heneidy A, Seale H, et al. | Vaccine
Aim: To identify, analyse the characteristics of, and evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless.
INFECTION CONTROL
5/2/22
Gupta S, Jawanda MK | Eur J Neurol
Aim: To evaluate the number of published cases of Bell's palsy as the only major neurological manifestation in patients with COVID-19 from March 2020 to December 2021 and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
5/2/22
Kow CS, Ramachandram DS, Hasan SS | J Cardiovasc Pharmacol
Aim: To perform a systematic review and meta-analysis to determine the effect of preadmission/prediagnosis use of CCBs on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/22
Geng H, Cao K, Zhang J, et al. | Hum Vaccin Immunother
Aim: To synthesize the attitudes and determinants in vaccination hesitancy of college students.
INFECTION CONTROL
4/26/22
Alosaimi B, AlFayyad I, Alshuaibi S, et al. | BMC Sports Sci Med Rehabil
Aim: To measure the prevalence of CV complications suffered by COVID-19 athletic patients, explore the outcomes, optimal approaches to diagnoses, and safe return-to-play considerations.
CLINICAL CHARACTERISTICS
4/26/22
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
4/26/22
Deng J, Heybati K, Ramaraju HB, et al. | Infection
Aim: To assess and compare the relative efficacy and safety of anti-SARS-CoV-2 antibody regimens for COVID-19.
CANDIDATE THERAPEUTICS
4/26/22
Conti V, Sellitto C, Torsiello M, et al. | JAMA Netw Open
Aim: To identify DDIs that led to adverse clinical outcomes and/or adverse drug reactions in patients with COVID-19.
CANDIDATE THERAPEUTICS
4/26/22
Zhang SX, Batra K, Xu W, et al. | Epidemiol Psychiatr Sci
Aim: To provide meta-analytical evidence on mental health symptoms during COVID-19 among frontline healthcare workers, general healthcare workers, the general population and university students in Latin America.
MENTAL HEALTH
4/26/22
Sakur FJ, Ward K, Khatri NN, et al. | JMIR Hum Factors
Aim: To review how self-care behaviours have changed for people with chronic conditions during the COVID-19 pandemic, and what technology they have adopted to manage their conditions during that period.
UPDATED
MENTAL HEALTH
4/26/22
Romeo FJ, Barbagelata L, Chiabrando JG, et al. | Am J Ther
Aim: To conduct an updated systematic review and meta-analysis of randomized clinical trials to assess a potential benefit of colchicine in hospitalized patients with COVID-19 infection.
UPDATED
CANDIDATE THERAPEUTICS
4/22/22
Luo S, Liang Y, Wong THT, et al. | Int J Epidemiol
Aim: To summarize modifiable factors for coronavirus disease 2019 (COVID-19) suggested by Mendelian randomization studies.
UPDATED
4/22/22
Giannos P, Katsikas Triantafyllidis K, et al. | Front Neurol
Aim: To screen the current literature and provide a summary of the reported cases of SARS-CoV-2 infected patients presenting with persistent hiccups.
CLINICAL CHARACTERISTICS
4/21/22
Sankova MV, Nikolenko VN, Oganesyan MV, et al. | Curr Drug Targets
Aim: To evaluate the pathogenetic relationship between gut microbiota, immunological reactivity disruption and microbiota pathologies with the new coronavirus infection's course in order to substantiate the use of current drugs correcting gut microbiota during the SARS-CoV-2 pandemic.
4/21/22
Kastora S, Patel M, Carter B, et al. | Endocrinol Diabetes Metab
Aim: To analyse the collective and geographically stratified mortality, ICU admission, ventilation requirement, illness severity and discharge rate amongst patients with diabetes.
UPDATED
CLINICAL CHARACTERISTICS
4/21/22
Vinayagamoorthy K, Pentapati KC, Prakash H | Mycoses
Aim: To address the prevalence, underlying diseases, iatrogenic risk factors, treatment and outcome of C. auris infections in COVID-19 patients.
4/19/22
Crawshaw AF, Farah Y, Deal A, et al. | Lancet Infect Dis
Aim: Exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland.
INFECTION CONTROL
4/19/22
Chen C, Haupert SR, Zimmermann L, et al. | J Infect Dis
Aim: To examine the worldwide prevalence of post COVID-19 condition.
LONG COVID
4/19/22
Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. | Arch Iran Med
Aim: To evaluate the role of regulatory T cells (Tregs) as one of the main cells that maintain immune homeostasis.
CLINICAL CHARACTERISTICS
4/18/22
Haghshomar M, Shobeiri P, Brand S, et al. | J Eat Disord
Aim: To provide a comprehensive overview of symptoms of ED and metabolic changes during the COVID-19 confinement.
MENTAL HEALTH
4/18/22
Sabaghian T, Rommasi F, Omidi F, et al. | Bratisl Lek Listy
Aim: To collate the condition and risk factors of AKI and non-AKI COVID-19 patients and to investigate AKI incidence in high-risk patients.
CLINICAL CHARACTERISTICS
4/18/22
Sulakshana S, Nayak SS, Perumal S, et al. | Anesth Essays Res
Aim: To review the evidence on the occurance of heparin-induced thrombocytopenia in COVID-19
CANDIDATE THERAPEUTICS
4/18/22
Tasoudis PT, Arvaniti CK, Adamou AT, et al. | Eur J Intern Med
Aim: To assess the efficacy of IL-6 inhibitors compared to standard of care (SOC) in COVID-19 patients.
CANDIDATE THERAPEUTICS
4/18/22
Ling RR, Ramanathan K, Tan FL, et al. | Lancet Respir Med
Aim: To characterise the incidence of myopericarditis following COVID-19 vaccination, and compare this with non-COVID-19 vaccination.
INFECTION CONTROL
4/18/22
Lotan I, Lydston M, Levy M | J Neuroophthalmol
Aim: To summarize the available postmarketing data regarding the occurrence of neuro-ophthalmological and other ocular complications of the COVID-19 vaccines.
INFECTION CONTROL
4/14/22
Daniels NF, Burrin C, Chan T, et al. | Curr Dev Nutr
Aim: To explore the indirect effects of the first year of COVID-19 on obesity and its risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/14/22
Rahmati M, Shamsi MM, Khoramipour K, et al. | Rev Med Virol
Aim: To explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence.
CLINICAL CHARACTERISTICS
4/14/22
Panda SK, Mishra A, Pathak M | Cureus
Aim: To analyze the clinical outcomes and SARS-CoV-2 infectivity of neonates born to SARS-CoV-2 positive mothers in India from published literature.
4/14/22
Minkove SJ, Sun J, Li Y, et al. | Rev Med Virol
Aim: To analyse studies presenting the adjusted effects specifically of ICI therapy on either survival, a severe event, or need for hospitalisation in cancer patients presenting with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
4/14/22
Yang H, Rigsby M, Zhu X, et al. | HERD
Aim: To identify factors associated with LTCF residents' COVID-19 infections and the impacts of the pandemic and the corresponding preventive measures on residents' mental health and behavioral problems.
CLINICAL CHARACTERISTICS
4/14/22
Ludhiadch A, Paul SR, Khan R, et al. | Int J Neurosci
Aim: To summarize the available literature on SCV-2 induced ischemic Stroke and its subtypes.
MENTAL HEALTH
4/14/22
 | NSW Health COVID-19 Critical Intelligence Unit
4/14/22
Ortenzi M, Balla A, Botteri E, et al. | Minerva Surg
Aim: To offer a comprehensive overview of the most important recommendations by the International Guidelines about general surgery.
INFECTION CONTROL
4/14/22
Ghasemi S, Harmooshi NN, Rahim F | Diagn Pathol
Aim: To investigate the eligible studies for the sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection.
DIAGNOSTICS
4/14/22
Manothummetha K, Chuleerarux N, Sanguankeo A, et al. | JAMA Netw Open
Aim: To summarize current evidence on vaccine responses and identify risk factors for diminished humoral immune response in recipients of SOT.
4/14/22
Umbrello M, Venco R, Antonucci E, et al. | Minerva Anestesiol
Aim: To investigate the incidence, risk factors and clinical outcomes of barotrauma among critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
4/14/22
Modica G, Bianco M, Sollazzo F, et al. | Int J Environ Res Public Health
Aim: To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/14/22
Ulbrichtova R, Svihrova V, Svihra J | Int J Environ Res Public Health
Aim: To evaluate the prevalence of COVID-19 vaccination among medical students worldwide.
UPDATED
CANDIDATE THERAPEUTICS
4/14/22
Vieira AGDS, Pinto ACPN, Garcia BMSP, et al. | J Physiother
Aim: To review the evidence on the effectiveness and safety of telerehabilitation for people with COVID-19 and post-COVID-19 conditions.
UPDATED
CANDIDATE THERAPEUTICS
4/14/22
Wang H, Li N, Sun C, et al. | Am J Emerg Med
Aim: To explore whether pregnancy increases the risk of adverse outcomes of COVID-19.
MENTAL HEALTH
4/14/22
Su W, Wang H, Sun C, et al.  | Am J Prev Med
Aim: To assess the association between previous influenza vaccination and COVID-19 on the basis of the available evidence.
UPDATED
4/14/22
Jia L, Carter MV, Cusano A, et al. | Am J Sports Med
Aim: To investigate the effect of the COVID-19 pandemic on the mental and emotional health of athletes and to identify risk factors associated with poor mental health outcomes.
INFECTION CONTROL
4/11/22
Litwinowicz K, Choroszy M, Ornat M, et al. | Sci Rep
Aim: To provide a comprehensive evaluation of the face masks and disposable FFRs effects on human physiology during low, moderate, and high-intensity activities.
UPDATED
INFECTION CONTROL
4/11/22
Palaiodimou L, Stefanou MI, de Sousa DA, et al. | J Neurol
Aim: To better characterize TTS-associated CVST, along with the therapeutic and prognostic implications, compared to non-TTS–CVST cases.
INFECTION CONTROL
4/11/22
Koupaei M, Mohamadi MH, Yashmi I, et al. | J Clin Lab Anal
Aim: To evaluate the features of COVID-19 relapse patients.
CLINICAL CHARACTERISTICS
4/11/22
Huang D, Zunong J, Li M, et al. | Curr HIV/AIDS Rep
Aim: To review the evidence on the epidemiological characteristics and clinical presentation of coinfected patients in China, as well as laboratory indicators, antiretroviral therapy status, and disease outcomes in PLHIV coinfected with CoV.
CLINICAL CHARACTERISTICS
4/11/22
Perry J, Osman S, Wright J, et al. | PLoS One
Aim: To assess the evidence for a humoral CoP for SARS-CoV-2.
INFECTION CONTROL
4/11/22
Boden I, Bernabeu MO, Dhillon B, et al. | Diabetes Res Clin Pract
Aim: To test the hypothesis that pre-existing diabetic retinopathy (DR), a microvascular disease, is a prognostic indicator for poor COVID-19 outcome in this heterogeneous population.
CLINICAL CHARACTERISTICS
4/11/22
Chaudhry ZS, Nellessen N, Reis C, et al. | Fam Pract
Aim: To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19.
CLINICAL CHARACTERISTICS
4/11/22
Edilgireeva LA, Sadulaeva TA, Zakharov VV, et al. | Zh Nevrol Psikhiatr Im S S Korsakova
Aim: To assess the effect of antiplatelet therapy on the risk of thrombotic complications and disease course in SARS-COV-2 infected patients.
CANDIDATE THERAPEUTICS
4/11/22
Thornton GM, Fleck BA, Fleck N, et al. | PLoS One
Aim: To examine the effectiveness of HVAC design features in reducing virus transmission.
UPDATED
INFECTION CONTROL
4/8/22
Nawabi NLA, Duey AH, Kilgallon JL, et al. | J Neurointerv Surg
Aim: To review the evidence on how COVID-19 affected stroke response times.
INFECTION CONTROL
4/8/22
Wake AD | Glob Pediatr Health
Aim: To evaluate the potential intrauterine vertical transmission of a novel SARS-CoV-2 among confirmed cases of pregnant women.
MENTAL HEALTH
4/8/22
Han P, Duan X, Zhao S, et al. | Front Public Health
Aim: To summarize and evaluate the actual psychological experience of nurses caring for patients with severe pneumonia in the ICUs during the COVID-19 pandemic.
4/8/22
Marmitt DJ | Inflammopharmacology
Aim: To select clinical trials with anti-inflammatory plants and relate the activity of these plants to inflammatory markers of SARS-CoV-2 infection.
4/8/22
Fallah-Aliabadi S, Fatemi F, Heydari A, et al. | Public Health Nurs
Aim: To identify and categorize social vulnerability indicators in the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
4/7/22
Hopefl R, Ben-Eltriki M, Deb S | J Pharm Pharm Sci
Aim: To analyze the association of vitamin D levels with the inflammatory markers in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/7/22
Rahmani AM, Azhir E, Naserbakht M, et al. | Multimed Tools Appl
Aim: To review the evidence on the application of Machine Learning (ML) methods for the detection of COVID-19.
DIAGNOSTICS
4/7/22
Naimi A, Yashmi I, Jebeleh R, et al. | J Clin Lab Anal
Aim: To review the literature reporting the COVID-19 outcomes in patients with hematological malignancies.
CLINICAL CHARACTERISTICS
4/7/22
Fu XL, Qian Y, Jin XH, et al. | Lupus
Aim: To evaluate the epidemiology of SLE and COVID-19, to identify the clinical characteristics of SLE patients with COVID-19, to clarify the treatment of COVID-19 in SLE patients and to assess the impact of COVID-19 pandemic on SLE patients.
CLINICAL CHARACTERISTICS
4/7/22
Yazdani A, Mirmosayyeb O, Ghaffary EM, et al. | Neurol Sci
Aim: To determine the pooled prevalence of vaccination willingness, unwillingness, and hesitancy among patients with multiple sclerosis.
INFECTION CONTROL
4/7/22
Alimoradi Z, Abdi F, Gozal D, et al. | BMJ Open
Aim: To estimate the sleep problems among pregnant women during the COVID-19 pandemic.
MENTAL HEALTH
4/7/22
Lee TC, Vigod S, Bortolussi-Courval É, et al. | JAMA Netw Open
Aim: To perform a meta-analysis of the available randomized clinical trial evidence for fluvoxamine in the outpatient management of COVID-19.
CANDIDATE THERAPEUTICS
4/7/22
Bhuta S, Khokher W, Kesireddy N, et al. | Am J Ther
Aim: To investigate the efficacy of fluvoxamine in nonhospitalized patients with acute COVID-19 infection.
CANDIDATE THERAPEUTICS
4/7/22
Fadlalla M, Ahmed M, Ali M, et al. | Curr Pharmacol Rep
Aim: To review and summarize research of FDA-approved drugs repurposed against SARS-CoV-2 virus.
CANDIDATE THERAPEUTICS
4/7/22
Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al.  | J Clin Lab Anal
Aim: To evaluate the prevalence of neurological complications arises from SARS-CoV-2 and assess the mortality rate from neurological complications.
CLINICAL CHARACTERISTICS
4/7/22
Yasmin F, Najeeb H, Moeed A, et al.  | PLoS One
Aim: To evaluate the safety profile of colchicine in COVID-19 patients using the gold-standard randomised-control trials.
CANDIDATE THERAPEUTICS
4/7/22
James D, Jena A, Bharath PN, et al. | Dig Liver Dis
Aim: To review the evidence on the various adverse events following COVID-19 vaccination in patients with IBD in order to inform the clinicians and patients regarding the (lack of) risks) of COVID vaccination.
INFECTION CONTROL
4/7/22
J Devoe D, Han A, Anderson A, et al. | Int J Eat Disord
Aim: To synthesize the impact of the COVID-19 pandemic on individuals with EDs.
UPDATED
MENTAL HEALTH
4/6/22
Gupta AK, Leslie A, Hewitt JN, et al. | ANZ J Surg
Aim: To characterize outcomes of COVID-19 positive patients undergoing cardiac surgery.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Bailey CJ, Gwilt M | Front Pharmacol
Aim: To review the clinical literature on clinical outcomes in metformin-treated subjects presenting with Covid-19.
CANDIDATE THERAPEUTICS
4/6/22
Theberath M, Bauer D, Chen W, et al. | SAGE Open Med
Aim: To summarize existing survey studies addressing the effects of the current COVID-19 pandemic on the mental health of children and adolescents.
MENTAL HEALTH
4/6/22
Gao Y, Bagheri N, Furuya-Kanamori L | Z Gesundh Wiss
Aim: To investigate the impact of the coronavirus lockdowns on ED symptoms severity and summarize factors associated with lockdowns that led to changes in eating disorders.
MENTAL HEALTH
4/6/22
Iheanacho CO, Eze UIH | Futur J Pharm Sci
Aim: To evaluate the clinical and laboratory features associated with BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines, to determine their immunogenicity.
INFECTION CONTROL
4/6/22
Rauniyar R, Mishra A, Kharel S, et al. | Can J Infect Dis Med Microbiol
Aim: To evaluate the optimal treatment using IVIG alone versus IVIG plus glucocorticoids.
CANDIDATE THERAPEUTICS
4/6/22
Liu M, Mei K, Tan Z, et al.  | Can J Gastroenterol Hepatol
Aim: To evaluate the relationship between liver fibrosis scores and adverse outcomes in patients with COVID-19, as well as potential dose-response association.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Calvert C, John J, Nzvere FP, et al. | Glob Health Action
Aim: To report the findings of a rapid systematic review of studies on levels of maternal mortality before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Moya-Salazar J, Nuñez E, Jaime-Quispe A, et al. | Subst Abuse
Aim: To determine the frequency of substance use among Latin American HCWs.
MENTAL HEALTH
4/5/22
Ao G, Li A, Wang Y, et al. | Am J Emerg Med
Aim: To investigate the association between opioid usage and COVID-19 prognosis.
UPDATED
4/4/22
Patanavanich R, Siripoon T, Amponnavarat S, et al. | Nicotine Tob Res
Aim: To explore the association between current smoking and the risk for mortality due to COVID-19.
CLINICAL CHARACTERISTICS
4/4/22
Fomenko A, Weibel S, Moezi H, et al. | Rev Med Virol
Aim: To review the evidence on RT-PCR performance in detecting infectious SARS-CoV-2. 
UPDATED
DIAGNOSTICS
4/4/22
Silverberg SL, Zhang BY, Li SNJ, et al.  | BMC Pediatr
Aim: To identify the role of children in SARS-CoV-2 transmission to other children and adults.
INFECTION CONTROL
4/4/22
Wang Y, Kang L, Chien CW, et al. | Front Cardiovasc Med
Aim: To compare the characteristics, management, and clinical outcomes between the COVID-19 and non-COVID-19 patients concomitant STEMI.
UPDATED
CLINICAL CHARACTERISTICS
4/4/22
Mondal R, Mishra S, Pillai JSK, et al. | J Family Prim Med Care
Aim: To identify the impacts of the pandemic on biomedical waste management. 
4/4/22
Mohanty RR, Biswa Mohan Padhy, Meher BR | J Pharm Pharm Sci
Aim: To determine the efficacy and safety of the pulse dose methyl prednisolone in management of COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
4/4/22
Len P, Iskakova G, Sautbayeva Z, et al. | Front Cardiovasc Med
Aim: To assess the association between early hemostatic parameters and infection severity.
CLINICAL CHARACTERISTICS
4/4/22
Yang F, Xu Y, Dong Y, et al. | Pancreatology
Aim: To determine the pooled prevalence and prognostic significance of increased pancreatic enzymes in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
4/4/22
Mazidimoradi A, Alemzadeh E, Alemzadeh E, et al. | Life Sci
Aim: To evaluate the effect of polyunsaturated fatty acids on the prognosis of Covid-19 disease.
CANDIDATE THERAPEUTICS
4/4/22
Mirhashemi A, Khami MR, Kharazifard M, et al. | Front Public Health
Aim: To systematically review the relationship between oral habits (bruxism- temporomandibular disorders) and COVID-19 pandemic in adults and adolescents.
MENTAL HEALTH
4/1/22
van Mulukom V, Pummerer LJ, Alper S, et al. | Soc Sci Med
Aim: To provide a comprehensive overview of the available research on COVID-19 conspiracy beliefs and to synthesise this research to make it widely accessible.
INFECTION CONTROL
4/1/22
Khedr A, Al Hennawi H, Rauf I, et al. | Infez Med
Aim: To assess and compare mortality outcomes between LMICs and high-income countries (HICs).
CLINICAL CHARACTERISTICS
4/1/22
El-Qushayri AE, Mahmoud MA, Salman S, et al. | Dermatol Ther
Aim: To evaluate the safety of dupilumab use in the management of atopic dermatitis (AD) during the current pandemic regarding the risk and the hazards of COVID-19 infection.
CLINICAL CHARACTERISTICS
4/1/22
Bhurwal A, Mutneja H, Bansal V, et al. | Aliment Pharmacol Ther
Aim: To summarize the available literature regarding the safety and effectiveness of SARS-CoV-2 vaccine in IBD.
INFECTION CONTROL
4/1/22
Yasuda H, Mayumi T, Okano H | Infection
Aim: To examine the effects of anticoagulant doses administered to patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
4/1/22
Kim DH, Kim SW, Kang M, et al. | Clin Otolaryngol
Aim: To assess the effect of topical steroids on acute-onset olfactory dysfunction in patients infected with COVID-19.
CANDIDATE THERAPEUTICS
4/1/22
Ma BM, Tam AR, Chan KW, et al. | Front Med
Aim: To review the evidence on the efficacy and safety of COVID-19 vaccine in patients on RRT.
UPDATED
INFECTION CONTROL
4/1/22
Patterson PD, Mcilvaine QS, Nong L, et al. | J Am Coll Emerg Physicians Open
Aim: To assess the evidence regarding masking in the workplace during the initial months of the COVID?19 pandemic.
INFECTION CONTROL
4/1/22
Wang F, Ma Y, Xu S, et al. | Clin Rheumatol
Aim: To assess the risk of COVID-19 in patients with rheumatic diseases.
CLINICAL CHARACTERISTICS
4/1/22
Su Y, Rao W, Li M, et al. | Int Psychogeriatr
Aim: To provide up-to-date pooled estimates of the prevalence of social isolation and loneliness among older adults during the COVID-19 pandemic and other pandemics in the last two decades.
UPDATED
MENTAL HEALTH
4/1/22
Figueiredo EAB, Silva WT, Tsopanoglou SP, et al. | Rev Soc Bras Med Trop
Aim: To discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization.
CLINICAL CHARACTERISTICS
3/31/22
Liu G, Chen Y, Runa A, et al. | Eur Radiol
Aim: To provide an updated overview of the diagnostic performance of CO-RADS in COVID-19, with a focus on the possible practical application of CO-RADS.
DIAGNOSTICS
3/31/22
Diallo A, Carlos-Bolumbu M, Diallo MH, et al. | Z Gesundh Wiss
Aim: To optimize vaccination strategy, evidence on vaccine efficacy against COVID-19 is needed.
UPDATED
INFECTION CONTROL
3/31/22
Abdel-Gawad M, Zaghloul MS, Abd-Elsalam S, et al. | Antiinflamm Antiallergy Agents Med Chem
Aim: To assess the prevalence of post-COVID-19 manifestations.
LONG COVID
3/31/22
de Oliveira YLM, de Sa Resende A, Martins-Filho PR, et al. | Inflammopharmacology
Aim: To evaluate the expression of TREM-1 in patients with COVID-19 and other viral pneumonias compared to healthy individuals.
CLINICAL CHARACTERISTICS
3/31/22
Hong S, Wang H, Zhang Z, et al. | Steroids
Aim: To evaluate the efficacy and safety of methylprednisolone in the treatment of patients with COVID-19 compared with no corticosteroids therapy.
CANDIDATE THERAPEUTICS
3/30/22
Zheng W, Sun HL, Cai H, et al. | J Affect Disord
Aim: To evaluate the efficacy and safety of adjunctive antidepressants for COVID-19 patients.
CANDIDATE THERAPEUTICS
3/30/22
Yu SY, Koh DH, Choi M, et al.  | Emerg Microbes Infect
Aim: To investigate the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CANDIDATE THERAPEUTICS
3/30/22
Almamlouk R, Kashour T, Obeidat S, et al. | Clin Microbiol Infect
Aim: To better understand the pathologic cardiac findings in COVID-19 patients at the time of postmortem evaluation.
CLINICAL CHARACTERISTICS
3/30/22
Zuin M, Bilato C, Quadretti L, et al. | G Ital Cardiol
Aim: To determine the in-hospital incidence of acute PE, based on Italian studies published on this issue.
CLINICAL CHARACTERISTICS
3/30/22
Kim AY, Woo W, Yon DK, et al. | Int J Infect Dis
Aim: To meta-analyze the clinical manifestations, diagnosis, treatment, and mortality of vaccine-induced immune thrombotic thrombocytopaenia (VITT) after adenoviral vector vaccination.
INFECTION CONTROL
3/28/22
Whited N, Cervantes J | Breastfeed Med
Aim: To investigate the presence of antibodies to SARS-CoV-2 in human breast milk after vaccination.
INFECTION CONTROL
3/28/22
Asiimwe IG, Pushpakom SP, Turner RM, et al. | Br J Clin Pharmacol
Aim: To review the evidence on cardiovascular drug exposure and COVID-19 clinical outcomes.
CLINICAL CHARACTERISTICS
3/28/22
Beran A, Mhanna M, Srour O, et al. | Clin Nutr ESPEN
Aim: To provide a quantitative assessment of the clinical significance of micronutrient supplements in patients with COVID-19.
CANDIDATE THERAPEUTICS
3/28/22
García H, Allende-López A, Morales-Ruíz P, et al. | Arch Med Res
Aim: To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT–PCR test.
CLINICAL CHARACTERISTICS
3/28/22
Sriwastava S, Sharma K, Khalid SH, et al. | Brain Sci
Aim: To discern CNS and PNS manifestations following the COVID-19 vaccine to help produce methods to mitigate them. 
INFECTION CONTROL
3/28/22
Patwary MM, Alam MA, Bardhan M, et al. | Vaccines
Aim: To estimate COVID-19 vaccine acceptance and hesitance rates among the people of LMICs.
INFECTION CONTROL
3/28/22
Co M, Wong PCP, Kwong A | Cancer Treat Res Commun
Aim: To evaluate the best available evidence of axillary lymphadenopathy after COVID-19 vaccination.
INFECTION CONTROL
3/28/22
Alboksmaty A, Beaney T, Elkin S, et al. | Lancet Digit Health
Aim: To assess the effectiveness and safety of the use of pulse oximetry in the remote monitoring of patients at home with COVID-19.
UPDATED
3/28/22
Gao P, Cai S, Liu Q, et al. | Vaccines
Aim: To evaluate the effectiveness and safety of SARS-CoV-2 vaccines in children and adolescents.
INFECTION CONTROL
3/28/22
Ghazy RM, Ashmawy R, Hamdy NA, et al. | Vaccines
Aim: To assess the efficacy and effectiveness of COVID-19 vaccines to prevent mortality and reduce the risk of developing severe disease after the 1st and 2nd doses.
INFECTION CONTROL
3/28/22
Garcia-Sanchez A, Peña-Cardelles JF, Ruiz S, et al. | J Clin Med
Aim: To evaluate the efficacy of different mouthwashes on the reduction of salivary viral load of SARS-CoV-2 in COVID-19 positive patients confirmed with RT-PCR tests as pre-procedural rinses.
INFECTION CONTROL
3/28/22
Fabbri L, Moss S, Khan FA, et al. | Thorax
Aim: To assess the proportion of chest CT scans and pulmonary function tests consistent with parenchymal lung disease in the follow-up of people hospitalised with COVID-19 and viral pneumonitis.
CLINICAL CHARACTERISTICS
3/28/22
Maglietta G, Diodati F, Puntoni M, et al. | J Clin Med
Aim: To identify, in patients who had been hospitalized for COVID-19, which factors already present or emerging during hospitalization, were associated with an increased risk of exhibiting new or persisting symptoms.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Gentile F, Bocci T, Coppola S, et al. | Biomedicines
Aim: To discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19.
CLINICAL CHARACTERISTICS
3/28/22
De Rose DU, Salvatori G, Dotta A, et al. | Viruses
Aim: To summarize current knowledge about maternal and neonatal outcomes following COVID-19 vaccination during pregnancy and breastfeeding. 
INFECTION CONTROL
3/28/22
Riccò M, Ferraro P, Peruzzi S, et al. | Microorganisms
Aim: To summarize the available data about the risk of co-infections SARS-CoV-2–Legionella, specifically focusing on their prevalence, risk factors, and two main outcomes—ICU admission and case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
3/28/22
Li S, Ren J, Hou H, et al. | Neurol Sci
Aim: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
3/28/22
Batteux E, Mills F, Jones LF, et al. | Vaccines
Aim: To identify and evaluate the effectiveness of interventions which can increase COVID-19 vaccine uptake.
UPDATED
INFECTION CONTROL
3/28/22
Furnica C, Chistol RO, Chiran DA, et al. | Diagnostics
Aim: To evaluate the impact of the early COVID-19 pandemic on the presentation, management, and prognosis of STEMI patients.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Fatima K, Almas T, Lakhani S, et al. | Trop Med Infect Dis
Aim: To address the relationship between the use of PPI and the severity of COVID-19 infection.
INFECTION CONTROL
3/28/22
Bania A, Pitsikakis K, Mavrovounis G, et al. | J Pers Med
Aim: To summarize the most recent evidence regarding the therapeutic role of vitamin D on severe COVID-19 outcomes (length of hospital stay, mechanical ventilation, mortality) in adult populations.
UPDATED
CANDIDATE THERAPEUTICS
3/28/22
Decyk A, Kobylinska M, Antosik K, et al. | Rocz Panstw Zakl Hig
Aim: To review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/25/22
Seirafianpour F, Pourriyahi H, Mesgarha MG, et al. | Dermatol Ther
Aim: To review the evidence on the dermatologic side effects of COVID-19 vaccinations.
INFECTION CONTROL
3/25/22
Muthuka JK, Kiptoo M, Oluoch K, et al. | JMIR Pediatr Parent
Aim: To examine the relationship between pregnancy status and the clinical COVID -19 severity characterized by cytokine storm.
UPDATED
CLINICAL CHARACTERISTICS
3/25/22
Jefferson L, Golder S, Heathcote C, et al. | Br J Gen Pract
Aim: To synthesise international evidence exploring the impact of COVID-19 on primary care doctors' mental health and wellbeing, and identify risk factors associated with their psychological wellbeing during this time.
MENTAL HEALTH
3/25/22
Beran A, Srour O, Malhas SE, et al.  | Respir Care
Aim: To evaluate the effect of HFNC vs. NIV in COVID-19-related AHRF.
CANDIDATE THERAPEUTICS
3/25/22
He Y, Liu N, Zhuang X, et al. | Ther Adv Respir Dis
Aim: To compare the effectiveness and value of high-flow nasal cannula (HFNC) with noninvasive ventilation (NIV) for COVID-19 patients.
CANDIDATE THERAPEUTICS
3/25/22
Tan CJ, Tan BKJ, Tan XY, et al. | Laryngoscope
Aim: To review the evidence on the pathogenesis of COVID-19 olfactory dysfunction.
CLINICAL CHARACTERISTICS
3/25/22
Mutua V, Henry BM, Csefalvay CV, et al. | Acta Biomed
Aim: To explore the clinical benefits and safety of tocilizumab in addition to standard of care (SOC) in treating patients with coronavirus disease 2019 (COVID-19).
UPDATED
CANDIDATE THERAPEUTICS
3/25/22
Helman SN, Adler J, Jafari A, et al. | Allergy Asthma Proc
Aim: To review the evidence on the medical and procedural treatment options for PVOD.
CANDIDATE THERAPEUTICS
3/24/22
Bhakta S, Erben Y, Sanghavi D, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To assess the association between race and VTE in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
3/24/22
Bitterman A, Martins CP, Cices A, et al. | JAMA Netw Open
Aim: To evaluate the association between regional prevalence of strongyloidiasis and ivermectin trial results for the outcome of mortality by testing the hypothesis that strongyloidiasis prevalence interacts with the RR of mortality.
CANDIDATE THERAPEUTICS
3/24/22
Jeon SR, Kang JW, Ang L, et al. | Integr Med Res
Aim: To create an evidence map which includes information for the CAM interventions according to what those interventions have strong evidence and those that need further testing.
CANDIDATE THERAPEUTICS
3/24/22
Farsi Y, Tahvildari A, Arbabi M, et al. | Front Cell Infect Microbiol
Aim: To evaluate the composition of gut microbiota in COVID-19 patients compared with healthy individuals.
CLINICAL CHARACTERISTICS
3/24/22
Alimoradi Z, Ohayon MM, Griffiths MD, et al. | BJPsych Open
Aim: To synthesize empirical evidence to understand fear of COVID-19 and its associations with mental health-related problems during this pandemic period.
UPDATED
3/24/22
Seyferth AV, Wood SM, Kane RL, et al. | Plast Reconstr Surg
Aim: To quantify the prevalence of ethical discussions and representation of the four ethical principles in COVID-19 research, and to identify which principles and topics are underrepresented across scientific disciplines.
3/24/22
Tutal E, Ozaras R, Leblebicioglu H | Travel Med Infect Dis
Aim: To assess the prevalence, clinical features and outcome of autoimmune thyroid disorders triggered by COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/21/22
Crivelli L, Palmer K, Calandri I, et al. | Alzheimers Dement
Aim: To review the evidence on the cognitive effects of coronavirus disease 2019 (COVID-19) in adults with no prior history of cognitive impairment.
UPDATED
MENTAL HEALTH
3/21/22
Wang F, Zhang L, Ding L, et al. | Front Public Health
Aim: To review the evidence on the fear among college students during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
3/21/22
Lee KW, Ang CS, Lim SH, et al.  | HIV Med
Aim: To assess the prevalence of depression, anxiety, psychological stress, insomnia and loneliness among PLHIV during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
3/21/22
Allotey J, Chatterjee S, Kew T, et al.  | BMJ
Aim: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
CLINICAL CHARACTERISTICS
3/21/22
Huang YZ, Kuan CC | Eur Rev Med Pharmacol Sci
Aim: To examine the efficacy of different types of vaccines in reducing hospitalization rates, disease severity, and mortality.
INFECTION CONTROL
3/18/22
Kumar R, Rai AK, Phukan MM, et al. | Curr Genomics
Aim: To assess the cumulative risk assessment of multiple co-morbid conditions associated with severe COVID-19. 
CLINICAL CHARACTERISTICS
3/18/22
Ashktorab H, Russo T, Oskrochi G, et al. | Gastro Hep Adv
Aim: To analyze data from studies reporting Gastrointestinal bleeding (GIB) and/or endoscopic findings in COVID-19 patients in Western countries.
CLINICAL CHARACTERISTICS
3/18/22
Gatti M, Rinaldi M, Bussini L, et al. | Clin Microbiol Infect
Aim: To assess the clinical outcome in SOT recipients with COVID-19 compared to general population.
CLINICAL CHARACTERISTICS
3/18/22
Glenardi G, Chriestya F, Oetoro BJ, et al. | Acute Crit Care
Aim: To investigate the efficacy of HFNC compared to NIV in COVID-19 patients.
CANDIDATE THERAPEUTICS
3/18/22
Rawal S, Tackett RL, Stone RH, et al. | Am J Obstet Gynecol MFM
Aim: To identify and synthesize what is known about COVID-19 vaccination amongst pregnant people in the U.S., including safety, effectiveness, acceptance, hesitancy, and uptake of COVID-19 vaccinations.
UPDATED
INFECTION CONTROL
3/18/22
Mekonnen BD, Mengistu BA | Clin Epidemiol Glob Health
Aim: To estimate the pooled proportion of COVID-19 vaccine acceptance and its determinants in Ethiopia.
UPDATED
INFECTION CONTROL
3/18/22
Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al.  | Ann Med Surg
Aim: To provide a detailed account of the development of myocarditis and pericarditis following the COVID-19 vaccination
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Nikpour M, Sepidarkish M, Omidvar S, et al. | Expert Rev Vaccines
Aim: To evaluate the acceptance of a coronavirus disease 2019 (COVID-19) vaccine among pregnant women and its determinants.
INFECTION CONTROL
3/18/22
Hartwell M, Lin V, Gatewood A, et al.  | J Matern Fetal Neonatal Med
Aim: To examine the inclusion of the equity reporting in SRMAs focused on pregnancy outcomes and COVID-19 using PROGRESS-Plus equity framework.
CLINICAL CHARACTERISTICS
3/18/22
Gong X, Yuan B, Yuan Y | PLoS One
Aim: To assess the pooled incidence of pulmonary embolic events and the prognostic value of such events in intensive care unit (ICU) admissions of patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Perez-Lopez FR, Saviron-Cornudella R, Chedraui P, et al. | J Matern Fetal Neonatal Med
Aim: To compare obstetric and perinatal outcomes in laboratory-tested pregnant women for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection before delivering.
CLINICAL CHARACTERISTICS
3/18/22
Qi X, Northridge ME, et al. | Aging Health Res
Aim: To determine the prevalence of oral health conditions in participants with COVID-19 infection and identify the associations of oral health conditions with COVID-19 related outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Zou Y, Han M, Wang J, et al. | Ann Transl Med
Aim: To compare the mortality risk of frail vs. non-frail hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Jaiswal V, Almas T, Peng Ang S, et al. | Ann Med Surg
Aim: To find the symptoms, risk factors, clinical findings, and outcomes in patient of COVID-19 having STEMI.
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Ripp T, Roer JP, et al. | BMC Psychol
Aim: To review the evidence on the association between COVID-19-related conspiracy belief and infection-preventive behavior and vaccination willingness.
INFECTION CONTROL
3/18/22
Silva A, Azevedo M, Sampaio-Maia B, et al. | J Am Dent Assoc
Aim: To assess the effectiveness of mouthrinses in reducing SARS-CoV-2 viral load.
UPDATED
INFECTION CONTROL
3/18/22
Aem L, Morath LP, Burstrom B, et al. | BMC Health Serv Res
Aim: To examine the impact of facility and staff characteristics on the risk of infectious disease outbreaks in care homes.
INFECTION CONTROL
3/18/22
Kamal L, Ramadan A, Farraj S, et al. | Saudi Pharm J
Aim: To review the evidence on molnupiravir safety and anti-viral activity.
CANDIDATE THERAPEUTICS
3/18/22
Mbunge E, Batani J, Gaobotse G, et al. | Glob Health J
Aim: To identify virtual healthcare services and digital health technologies deployed in South Africa during coronavirus disease 2019 (COVID-19) and the challenges associated with their use.
INFECTION CONTROL
3/14/22
Argano C, Mallaci Bocchio R, Lo Monaco M, et al.  | Int J Mol Sci
Aim: To assess the association between vitamin D supplementation and inflammatory markers in patients with diabetes; furthermore, vitamin D’s possible role in COVID-19 patients was assessed as well.
CANDIDATE THERAPEUTICS
3/14/22
Cao C, Gan X, Hu X, et al. | Aging
Aim: To evaluate the relationship between active immunotherapy and outcomes of cancer patients who had concurrent COVID-19 infection.
CANDIDATE THERAPEUTICS
3/14/22
Kaya T, Dilek A, Ozaras R, et al. | Travel Med Infect Dis
Aim: To evaluate COVID-19 cases presented with febrile neutropenia and provide information regarding incidence, clinical course and prognosis.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Chen W, Yin C, Zhong M, et al. | Ann Palliat Med
Aim: To identify studies systematically that describe the incidence and outcome of COVID-19-related pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
3/14/22
Branjerdporn G, Bowman C, Kenworthy S, et al. | Front Psychiatry
Aim: To examine the impact of past viral epidemics on staff mental health interventional responses, with a specific focus on healthcare provider response in the context of the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
3/14/22
Garcia-Sanchez A, Peña-Cardelles JF, Ordonez-Fernandez E, et al.  | Int J Environ Res Public Health
Aim: To investigate the effectiveness of PVP-I used as a mouthwash to decrease the salivary viral load of SARS-CoV-2.
INFECTION CONTROL
3/14/22
Sharma P, Malik S, Wadhwan V, et al. | Rev Med Virol
Aim: To assess the prevalence of oral manifestations in COVID-19 confirmed individuals.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Centeno-Cortez AK, Diaz-Chavez B, Santoyo-Saavedra DR, et al. | Rev Med Inst Mex Seguro Soc
Aim: To sustain with scientific evidence the importance of respiratory physiotherapy and its effects on post-acute COVID-19 adult patients.
CANDIDATE THERAPEUTICS
3/14/22
Ojo O, Ojo OO, Feng Q, et al.  | Nutrients
Aim: To evaluate the effects of enteral nutrition in critically ill patients with COVID-19.
CANDIDATE THERAPEUTICS
3/11/22
 | NSW Health COVID-19 Critical Intelligence Unit
UPDATED
3/11/22
Chen H, Shi H, Liu X, et al. | Front Med
Aim: To evaluate the effect of PR on lung impairment for patients with post-COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/11/22
Tao K, Tzou PL, Pond SLK, et al. | Preprints.org
Aim: To review the evidence on the in vitro activity of authorized mAbs against the Omicron variants.
3/11/22
Abdelazeem B, Awad AK, Elbadawy MA, et al. | Drug Discov Ther
Aim: To evaluate the effects of curcumin in patients with COVID-19.
CANDIDATE THERAPEUTICS
3/10/22
Dao TL, Hoang VT, Colson P, et al. | J Clin Virol Plus
Aim: To determine the proportion of co-infection with influenza viruses in SARS-CoV-2 positive patients and to investigate the severity of COVID-19 in these patients.
CLINICAL CHARACTERISTICS
3/10/22
Griesel M, Wagner C, Mikolajewska A, et al. | Cochrane Database Syst Rev
Aim: To assess whether inhaled corticosteroids are effective and safe in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
3/10/22
Jari R, Alfuraih AM, McLaughlan JR | J Clin Ultrasound
Aim: To investigate the use of lung ultrasound (LUS) on COVID-19 patients, in emergency point of care settings, and to determine its diagnostic value compared with lung computed tomography (LCT) diagnostic performance.
DIAGNOSTICS
3/9/22
Kariyawasam RM, Julien DA, Jelinski DC, et al. | Antimicrob Resist Infect Control
Aim: To quantify the prevalence and types of resistant co-infecting organisms in patients with COVID-19 and explore differences across hospital and geographic settings.
UPDATED
3/9/22
Wang Y, Li Y, Zhang Y, et al. | BMC Gastroenterol
Aim: To investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
CLINICAL CHARACTERISTICS
3/9/22
Alzoughool F, Abumweis S, Alanagreh L, et al. | Osong Public Health Res Perspect
Aim: To evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality.
CLINICAL CHARACTERISTICS
3/9/22
Balawender K, Pliszka A, Krowiak A, et al. | Curr Pharm Biotechnol
Aim: To present the current understanding of the effects of Covid-19 infection on the male genitourinary system.
CLINICAL CHARACTERISTICS
3/9/22
Sanghavi D, Bansal P, Kaur IP, et al. | Ann Med
Aim: To evaluate the role of colchicine on morbidity and mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
3/9/22
Wafa IA, Pratama NR, Sofia NF, et al. | Diabetes Metab J
Aim: To investigate the differences in metabolic control parameters in diabetic patients before and during the lockdown.
UPDATED
CLINICAL CHARACTERISTICS
3/9/22
Beigi-Khoozani A, Merajikhah A, Soleimani M | Chin Med Sci J
Aim: To review the evidence on magnetic resonance imaging findings of olfactory bulb in anosmic patients with COVID-19.
CLINICAL CHARACTERISTICS
3/9/22
Soltani S, Zandi M, Faramarzi S, et al.  | Osong Public Health Res Perspect
Aim: To determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. 
CLINICAL CHARACTERISTICS
3/8/22
Martin-Martin J, Martin-Cazorla F, Suarez J, et al. | Curr Med Res Opin
Aim: To review complete autopsy cases and their postmortem findings and comorbidities associated with death caused by COVID-19.
CLINICAL CHARACTERISTICS
3/8/22
Yao J, Zhang Y, Wang XZ, et al.  | Front Public Health
Aim: To investigate the efficacy of flavonoids in treating viral ARTIs.
CANDIDATE THERAPEUTICS
3/8/22
Liao ZM, Zhang ZM, Liu Q | Ren Fail
Aim: To determine whether hydroxychloroquine/chloroquine increases the risk of acute kidney injury (AKI) in COVID-19 patients.
CANDIDATE THERAPEUTICS
3/8/22
SeyedAlinaghi S, Karimi A, Barzegary A, et al. | Health Sci Rep
Aim: To review the evidence on mucormycosis co?infection in patients with COVID?19.
CLINICAL CHARACTERISTICS
3/7/22
Macedo ACL, Prestes GDS, Colonetti T, et al. | J Clin Virol
Aim: To evaluate the accuracy of serology for SARS-CoV-2 infections in cases confirmed or not by RT-PCR.
DIAGNOSTICS
3/7/22
Flumignan RL, Civile VT, Tinôco JDS, et al. | Cochrane Database Syst Rev
Aim: To assess the benefits and harms of anticoagulants versus active comparator, placebo or no intervention in people hospitalised with COVID-19.
CANDIDATE THERAPEUTICS
3/7/22
Aguiar de Sousa D, Romoli M, Sanchez Van Kammen M, et al. | Stroke
Aim: To systematically review the incidence, clinical features, and prognosis of CVT occurring in patients with HIT.
INFECTION CONTROL
3/7/22
Domingues RB, Leite FBVM, Senne C | Arq Neuropsiquiatr
Aim: To review the evidence on CSF findings relating to COVID-19.
CLINICAL CHARACTERISTICS
3/7/22
Chenchula S, Karunakaran P | J Med Virol
Aim: To review the evidence on the efficacy of the COVID-19 booster dose vaccination against the Omicron variant.
INFECTION CONTROL
3/7/22
Zhang J, Chen C, Yang Y, et al. | Medicine
Aim: To investigate the effectiveness of tocilizumab in COVID-19 patients.
CANDIDATE THERAPEUTICS
3/7/22
Hu Y, Kung J, Cave A, et al. | J Pharm Pharm Sci
Aim: To determine the clinical effects of Vitamin D serum concentration in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
3/7/22
Hessami K, Aagaard K, Castro EC, et al. | Am J Perinatol
Aim: To review the evidence on histopathologic findings in the placentas of women with SARS-CoV-2 infection during pregnancy.
CLINICAL CHARACTERISTICS
3/7/22
Yan Y, Du X, Lai L, et al. | J Geriatr Psychiatry Neurol
Aim: To estimate the prevalence of depressive and anxiety symptoms among older adults with different health conditions can inform mental health services for this population during the corona virus disease-2019 (COVID-19) pandemic.
UPDATED
MENTAL HEALTH
3/4/22
Satpathy S, Wundaville LT, Satapathy S, et al. | J Patient Exp
Aim: To review the existing scales on patients’ satisfaction used for hospitalized patients and their application in COVID-19 situation. 
CLINICAL CHARACTERISTICS
3/4/22
Izcovich A, Siemieniuk RA, Bartoszko JJ, et al. | BMJ Open
Aim: To summarise specific adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir in patients with COVID-19.
CANDIDATE THERAPEUTICS
3/4/22
Lee ARYB, Wong SY, Chai LYA, et al. | BMJ
Aim: To compare the efficacy of COVID-19 vaccines between immunocompromised and immunocompetent people.
UPDATED
INFECTION CONTROL
3/4/22
Hu H, Pan H, Li R, et al. | Front Pharmacol
Aim: To identify the key factors associated to COVID-19 severity and death, especially in terms of the sex and race bias detected in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
3/4/22
Krzych LJ, Putowski Z, Gruca K, et al. | Pol Arch Intern Med
Aim: To review the evidence on mortality in critically ill COVID-19 patients with fungal infections.
CLINICAL CHARACTERISTICS
3/4/22
Goyal M, Ray I, Mascarenhas D, et al. | QJM
Aim: To elucidate the clinical findings, laboratory parameters, treatment and outcomes of individuals with Myocarditis after COVID-19 vaccination.
UPDATED
CLINICAL CHARACTERISTICS
3/4/22
Collings AT, Jeyarajah DR, Hanna NM, et al. | Surg Endosc
Aim: To examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved.
INFECTION CONTROL
3/4/22
Chua PEY, Gwee SXW, Wang MX, et al. | Front Med
Aim: To compare the accuracy of different diagnostic tests (molecular, serology, clinical features, point of care testing, and imaging) and assess their potential utility as border screening for infection and immunity against SARS-CoV-2.
DIAGNOSTICS
3/4/22
Quintero-Martinez JA, Hindy JR, Mahmood M, et al. | Am J Med Sci
Aim: To provide a descriptive analysis of the clinical features and outcomes of patients with IE and recent COVID-19.
CLINICAL CHARACTERISTICS
3/2/22
Nguyen B, Tosti A | JAAD Int
Aim: To characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia.
CLINICAL CHARACTERISTICS
3/2/22
Notarte KI, Guerrero-Arguero I, Velasco JV, et al.  | J Med Virol
Aim: To characterize the kinetics of anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) antibodies after the second dose of a primary cycle of COVID-19 mRNA vaccination. 
UPDATED
INFECTION CONTROL
3/2/22
Notarte KI, Ver AT, Velasco JV, et al.  | Crit Rev Clin Lab Sci
Aim: To review the evidence on the possible effects of age, sex, serostatus, and comorbidities on humoral response (i.e. total antibodies, IgG, and/or IgA) of different populations post-mRNA-based Pfizer-BioNTech vaccination.
CLINICAL CHARACTERISTICS
3/2/22
Kang X, Jin D, Jiang L, et al. | Chin Med
Aim: To evaluate the efficacy and explore the mechanisms of TCM for COVID-19. 
UPDATED
CANDIDATE THERAPEUTICS
3/2/22
Ben-Aicha S, Buchanan J, Punjabi P, et al. | Perfusion
Aim: To estimate the rate of in-hospital mortality following different treatments on COVID-19 in patients with CVD.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Damara FA, Muchamad GR, Anton, et al. | World Neurosurg
Aim: To evaluate the epidemiological characteristics of TBI patients before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
SeyedAlinaghi S, Karimi A, Mojdeganlou H, et al. | Health Sci Rep
Aim: To identify and summarize the impacts of the COVID?19 pandemic on routine vaccination coverage of children and adolescents.
INFECTION CONTROL
3/2/22
Ahmadieh A, Dincer S, Navazesh M | Oral Surg Oral Med Oral Pathol Oral Radiol
Aim: To assess the sensitivity rate of SARS-CoV-2 detection in the saliva of ambulatory asymptomatic and mildly symptomatic patients, with saliva being collected passively without any forceful coughing.
DIAGNOSTICS
3/2/22
Tayyebi H, Hasanikhah M, Heidarikhoo M, et al. | Curr Orthop Pract
Aim: To assess the in-hospital and 30-day mortality rates as well as the length of hospital stay in patients with COVID-19 infection who had hip fracture surgery.
CLINICAL CHARACTERISTICS
3/2/22
Kaka AS, MacDonald R, Linskens EJ, et al. | Ann Intern Med
Aim: To evaluate the effectiveness and harms of remdesivir for COVID-19.
UPDATED
VA ESP
CANDIDATE THERAPEUTICS
3/2/22
Mittal N, Mittal R, Gupta MC, et al.  | Worldviews Evid Based Nurs
Aim: To systematically review the literature to answer the question: "What is the worldwide prevalence of mental health effects in children and adolescents during the COVID-19 pandemic?".
UPDATED
MENTAL HEALTH
3/2/22
Lee ASY, Balakrishnan IDD, Khoo CY, et al. | Heart Lung Circ
Aim: To review the literature regarding myocarditis post COVID-19 vaccination, drawing from vaccine safety surveillance databases and case reports.
INFECTION CONTROL
3/2/22
Pashaei Z, SeyedAlinaghi S, Qaderi K, et al. | Health Sci Rep
Aim: The possible complications of COVID?19 infection in the fetus and newborn babies including the possibility and evidence of vertical transmission.
CLINICAL CHARACTERISTICS
3/2/22
Hannah JR, Ali SS, Nagra D, et al.  | Clin Exp Rheumatol
Aim: To review the evidence on skeletal muscle involvement in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Pechlivanidou E, Vlachakis D, Tsarouhas K, et al. | Food Chem Toxicol
Aim: To summarize and describe human studies investigating the prognostic role of micronutrient status and the effects of micronutrient supplementation intervention in COVID-19 outcomes of adult patients.
CANDIDATE THERAPEUTICS
2/28/22
Yuniar CT, Pratiwi B, Ihsan AF, et al.  | Vaccines
Aim: To summarize and critically evaluate the quality of harm reporting on randomized controlled trials for the COVID-19 vaccine and determine the factors associated with reporting quality.
INFECTION CONTROL
2/28/22
Pathirathna ML, Samarasekara BPP, Dasanayake TS, et al. | Healthcare
Aim: To evaluate the maternal, fetal and neonatal effects associated with COVID-19 in pregnancy.
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Saeed H, Eslami A, Nassif NT, et al. | Int J Environ Res Public Health
Aim: To investigate the prevalence and associations of anxiety in different sample populations in relation to the COVID-19 pandemic.
MENTAL HEALTH
2/28/22
Kim MS, Seong D, Li H, et al.  | Rev Med Virol
Aim: To evaluate the comparative effectiveness of N95, surgical/medical and non-medical facemasks as personal protective equipment against respiratory virus infection.
INFECTION CONTROL
2/28/22
Jorda A, Kussmann M, Kolenchery N, et al. | Front Immunol
Aim: To evaluate whether the use of convalescent plasma is associated with improved clinical outcomes in patients with Covid-19.
UPDATED
CANDIDATE THERAPEUTICS
2/28/22
El-Qushayri AE, Kamel AMA, Reda A, et al. | Rev Med Virol
Aim: To give a summary of the available literature regarding the outcomes of dengue and COVID-19 co-infection.
CLINICAL CHARACTERISTICS
2/28/22
Feikin DR, Higdon MM, Abu-Raddad LJ, et al. | Lancet
Aim: To systematically review the evidence for the duration of protection of COVID-19 vaccines against various clinical outcomes, and to assess changes in the rates of breakthrough infection caused by the delta variant with increasing time since vaccination.
INFECTION CONTROL
2/28/22
Szarpak L, Mierzejewska M, Jurek J, et al. | Biology
Aim: To determine the association between CAD and COVID-19 outcomes. 
CLINICAL CHARACTERISTICS
2/28/22
Ma Y, Deng J, Liu Q, et al. | Vaccines
Aim: To assess the effectiveness and safety of coronavirus disease 2019 (COVID-19) vaccines for pregnant women in real-world studies.
INFECTION CONTROL
2/28/22
Meggiolaro A, Sane Schepisi M, Nikolaidis GF, et al. | Vaccines
Aim: To assess the effectiveness of SARS-CoV-2 vaccines in terms of prevention of disease and transmission in the pre-Delta era. 
INFECTION CONTROL
2/28/22
Fragkou PC, De Angelis G, Menchinelli G, et al. | Clin Microbiol Infect
Aim: To identify the most appropriate diagnostic test and/or diagnostic approach for SARS-CoV-2. 
DIAGNOSTICS
2/28/22
Ahmadi Hekmatikar AH, Ferreira Júnior JB, Shahrbanian S, et al. | Int J Environ Res Public Health
Aim: To evaluate the effect of resistance or aerobic exercises in post-COVID-19 patients after hospital discharge. 
CANDIDATE THERAPEUTICS
2/28/22
Oyelade T, Alqahtani JS, Hjazi AM, et al. | Trop Med Infect Dis
Aim: To assess the prevalence of people living with HIV (PLWH) among COVID-19 cases and whether HIV infection affects the risk of severe COVID-19 or related death at the global and continental level. 
CLINICAL CHARACTERISTICS
2/28/22
Kariyawasam JC, Jayarajah U, Abeysuriya V, et al. | Am J Trop Med Hyg
Aim: To outline the important liver manifestations of COVID-19 and discussed the possible underlying pathophysiological mechanisms and their diagnosis and management.
CLINICAL CHARACTERISTICS
2/28/22
Han Q, Zheng B, Daines L, et al. | Pathogens
Aim: To systematically synthesise existing evidence on long-term post-COVID symptoms.
CLINICAL CHARACTERISTICS
2/28/22
Tian Y, Lu H, Liu X, et al. | Medicine
Aim: To assess whether tricuspid annular plane systolic excursion (TAPSE) could be used as a prognostic tool in patients with coronavirus disease 19 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Haseeb AA, Solyman O, Abushanab MM, et al. | Vaccines
Aim: To review the evidence on ocular complications following vaccination for COVID-19.
INFECTION CONTROL
2/28/22
Chen F, He Y, Shi Y | Vaccines
Aim: To estimate parents’ and guardians’ willingness to vaccinate their children against COVID-19 and identify the determinants of vaccination intention.
UPDATED
INFECTION CONTROL
2/28/22
Chen Q, Li W, Xiong J, et al. | Int J Environ Res Public Health
Aim: To estimate the influence of the COVID-19 pandemic on the prevalence of PPD and to summarize and determine risk factors for PPD during the COVID-19 pandemic.
MENTAL HEALTH
2/28/22
Ng JW, Chong ETJ, Tan YA, et al. | Int J Environ Res Public Health
Aim: To provide insight into the prevalence of COVID-19 in 5 different clinical stages during the outset of the COVID-19 pandemic in Malaysia.
CLINICAL CHARACTERISTICS
2/28/22
Tezcan B, Eraydin C, Karabacak BG | J Tissue Viability
Aim: To examine pressure ulcers in healthcare staff due to the use of protective equipment during COVID-19 pandemic and the precautions taken to prevent these injuries.
INFECTION CONTROL
2/28/22
Mendiola-Pastrana IR, López-Ortiz E, Río de la Loza-Zamora JG, et al. | Life
Aim: To analyze the impact of different SARS-CoV-2 variants on clinical outcomes.
CLINICAL CHARACTERISTICS
2/28/22
Halim C, Mirza AF, Sari MI | Pathogens
Aim: To determine the relationship, if any, between TNF-alpha, IL-6, vitamin D, and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
2/28/22
Ferrara P, Gianfredi V, Tomaselli V, et al. | Vaccines
Aim: To summarize the real-world data from epidemiological studies investigating the impact of smoking and on the humoral response after COVID-19 vaccination.
INFECTION CONTROL
2/28/22
Lluch C, Galiana L, Doménech P, et al. | Healthcare
Aim: To determine the level of burnout, compassion fatigue, and compassion satisfaction, as well as their associated risks and protective factors, in healthcare professionals during the first year of the COVID-19 pandemic. 
MENTAL HEALTH
2/28/22
Esposito M, Salerno M, Di Nunno N, et al. | Healthcare
Aim: To analyze all possible prevention techniques to reduce the risk of COVID-19 related infection within prisons. 
INFECTION CONTROL
2/28/22
Hashim NAF, Mahdy ZA, Abdul Rahman R, et al. | Front Public Health
Aim: To assess the justification for universal screening of pregnant women for COVID-19 prior to admission in labor through systematic review of antenatal prevalence of asymptomatic infection, hence risk of inadvertent spread of infection.
INFECTION CONTROL
2/28/22
Balboni E, Zagnoli F, Filippini T, et al. | J Trace Elem Med Biol
Aim: To review the evidence for possible effects of zinc or selenium on COVID-19, and therefore if there is any indication that increased intake of these trace elements is warranted and appropriate to prevent the current COVID-19 pandemic.
CANDIDATE THERAPEUTICS
2/25/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on budesonide and aspirin for pregnant women with COVID-19.
2/25/22
 | NSW Health COVID-19 Critical Intelligence Unit
2/25/22
Pipitone G, Rindi LV, Petrosillo N, et al.  | Infect Dis Rep
Aim: To review the evidence on vaccine-induced subacute thyroiditis (De Quervain's) after mRNA vaccine against SARS-CoV-2.
INFECTION CONTROL
2/24/22
An W, Wang Q, Kim TE, et al. | J Infect Public Health
Aim: To investigate the clinical characteristics, morbidity, severity, and mortality of COVID-19 infection among solid organ transplant (SOT) recipients by meta-analysis.
CLINICAL CHARACTERISTICS
2/24/22
Qaderi K, Golezar MH, Mardani A, et al. | Dermatol Ther
Aim: To summarize and integrated the findings of studies regarding cutaneous side effects of COVID-19 vaccines. 
UPDATED
INFECTION CONTROL
2/24/22
Abba-Aji M, Stuckler D, Galea S, et al. | J Migr Health
Aim: To review the evidence on ethnic minorities’ and migrants’ access to and acceptance of COVID-19 vaccines.
INFECTION CONTROL
2/24/22
Kunasekaran M, Quigley A, Rahman B, et al. | Open Forum Infect Dis
Aim: To explore the relationship of the physical layout of aged care facilities with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attack rates among residents.
INFECTION CONTROL
2/24/22
Li J, Wang Y, Liu Y, et al.  | Eur J Med Res
Aim: To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis.
UPDATED
CLINICAL CHARACTERISTICS
2/24/22
Isla A, Landy D, Teasdall R, et al. | Eur J Orthop Surg Traumatol
Aim: To explore the association of COVID-19 with short-term mortality in hip fracture patients.
CLINICAL CHARACTERISTICS
2/24/22
Hannemann J, Abdalrahman A, Erim Y, et al. | PLoS One
Aim: To summarize the evidence on the specific interplay of pandemic burden and psychosocial resources with regard to the mental health of HCWs during the COVID-19 pandemic. 
MENTAL HEALTH
2/24/22
Chen Q, Zhu K, Liu X, et al. | Emerg Microbes Infect
Aim: To review the evidence on the efficacy and duration of protection provided by naturally acquired immunity against subsequent SARS-CoV-2 infection.
INFECTION CONTROL
2/24/22
Fabião J, Sassi B, Pedrollo EF, et al. | Braz J Med Biol Res
Aim: To study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones.
UPDATED
CLINICAL CHARACTERISTICS
2/23/22
Jena A, James D, Singh AK, et al. | Clin Gastroenterol Hepatol
Aim: To systematically evaluate the seroconversion rates after complete COVID-19 vaccination in patients with inflammatory bowel disease (IBD).
INFECTION CONTROL
2/23/22
Wang Z, Zhao S, Tang Y, et al. | Eur J Pediatr
Aim: To evaluate the efficacy and safety of using potential drugs: remdesivir and glucocorticoid in treating children and adolescents with COVID-19 and intravenous immunoglobulin (IVIG) in treating MIS-C.
UPDATED
CANDIDATE THERAPEUTICS
2/22/22
Rottler M, Ocskay K, Sipos Z, et al. | Ann Intensive Care
Aim: To summarize the evidence on the efficacy of frailty tools in risk assessment in COVID-19 patients.
UPDATED
2/22/22
Heidary M, Asadi A, Noorbakhsh N, et al. | J Clin Lab Anal
Aim: To discuss the characteristics of COVID-19 in HIV-positive patients.
CLINICAL CHARACTERISTICS
2/22/22
Kamat M, Datar U, Byakodi S, et al. | J Clin Transl Res
Aim: To report and analyze CAM regarding risk factors, clinical characteristics and to understand the associated pathogenesis.
CLINICAL CHARACTERISTICS
2/22/22
Marciano L, Ostroumova M, Schulz PJ, et al. | Front Public Health
Aim: To review the evidence on the link between mental health and digital media use in adolescents during Covid-19.
MENTAL HEALTH
2/22/22
Pandey SR, Adhikari Yadav S, Gautam S, et al. | F1000Res
Aim: To evaluate the clinical and radiological effects of LDRT in patients with severe acute respiratory syndrome (SARS) due to COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/22/22
Camacho-Montaño LR, Iranzo A, Martínez-Piédrola RM, et al. | Sleep Med Rev
Aim: To examine the evidence of the effects of coronavirus disease confinement on the sleep of children aged 12 years and younger.
2/22/22
 | Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19.
UPDATED
2/22/22
Wang F, Wang D, Wang Y, et al. | Front Immunol
Aim: To identify the incidence rates of GBS that are temporally associated with viral vaccine administration but might not be attributable to the vaccines.
INFECTION CONTROL
2/22/22
Chu DK, Abrams EM, Golden DBK, et al.  | JAMA Intern Med
Aim: To assess the risk of severe immediate allergic reactions (eg, anaphylaxis) to a second dose of SARS-CoV-2 mRNA vaccine among persons with immediate allergic reactions to their first vaccine dose.
INFECTION CONTROL
2/22/22
Galanis P, Vraka I, Siskou O, et al. | Prev Med
Aim: To estimate parents' willingness and refusal to vaccinate their children against the COVID-19, and to investigate the predictors for their decision.
UPDATED
CANDIDATE THERAPEUTICS
2/21/22
Zhang G, Kuang S, Zhang X | Hum Vaccin Immunother
Aim: To evaluate the reporting quality of COVID-19 vaccine randomized controlled trials (RCTs).
2/21/22
Elvidge J, Summerfield A, Nicholls D, et al. | Value Health
Aim: To review economic evaluations of diagnostic tests and treatments for COVID-19.
UPDATED
2/21/22
Hossain AD, Jarolimova J, Elnaiem A, et al. | Lancet Public Health
Aim: To determine the effectiveness of contact tracing in the control of communicable illness.
INFECTION CONTROL
2/21/22
Ottisova L, Gillard JA, Wood M, et al. | J Trauma Stress
Aim: To summarize the evidence for the interventions in preventing or reducing adverse mental health outcomes in health care staff, with particular emphasis on PTSD, anxiety, depression, and sleep difficulties.
UPDATED
MENTAL HEALTH
2/21/22
Yelin D, Moschopoulos CD, Margalit I, et al. | Clin Microbiol Infect
Aim: To provide evidence-based recommendations for assessment and management of individuals with persistent symptoms after acute COVID-19 infection, and provide a definition for this entity, termed “long COVID”.
LONG COVID
2/21/22
Silveira FM, Mello ALR, da Silva Fonseca L, et al. | Arch Oral Biol
Aim: To integrate the morphological and tissue-based molecular characterization of oral lesions occurring in individuals infected by COVID-19 (OLICs).
UPDATED
CLINICAL CHARACTERISTICS
2/21/22
Pardamean E, Roan W, Iskandar KTA, et al. | Gen Hosp Psychiatry
Aim: To analyze whether patients with pre-existing schizophrenia are at higher risk for Covid-19 mortality.
UPDATED
MENTAL HEALTH
2/18/22
Yadav M, Singh A, Meena J, et al. | J Laryngol Otol
Aim: To review the evidence on the otorhinolaryngologic manifestations of COVID-19 in paediatric patients.
CLINICAL CHARACTERISTICS
2/18/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 pandemic and the wellbeing of critical care and other healthcare workers.
2/18/22
Caldeira D, Rodrigues BS, Alves M, et al. | Thromb J
Aim: To estimate the incidence of major bleeding events in this setting and to compare these risks against other vaccination routes.
INFECTION CONTROL
2/18/22
Du Z, Liu C, Wang C, et al. | Clin Infect Dis
Aim: To review the evidence on reproduction numbers of SARS-CoV-2 variants. 
2/18/22
Kazemi S, Pourgholaminejad A, Saberi A | Basic Clin Neurosci
Aim: To review the change of stroke incidence during the COVID-19 pandemic period and the proposed mechanisms of the relationship between SARS-CoV-2 and stroke.
CLINICAL CHARACTERISTICS
2/18/22
Hannum ME, Koch RJ, Ramirez VA, et al.  | Chem Senses
Aim: To establish the predicted prevalence rate of taste loss in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/18/22
Zhou JQ, Liu GX, Huang XL, et al. | J Med Virol
Aim: To review the evidence on the role of fecal nucleic acid detection of SARS-CoV-2 for quarantine and contact tracing.
DIAGNOSTICS
2/17/22
Di Felice G, Visci G, Teglia F, et al. | Elife
Aim: To compare the outcomes of unvaccinated COVID-19 patients with and without cancer.
CLINICAL CHARACTERISTICS
2/17/22
Xiao K, Gillissie ES, Lui LMW, et al. | J Affect Disord
Aim: To determine whether individuals with mental disorders exhibit differential immune response following the administration of vaccines for other infections.
2/17/22
Badenoch JB, Rengasamy ER, Watson C, et al. | Brain Commun
Aim: To determine the prevalence of neuropsychiatric symptoms in survivors of COVID-19.
UPDATED
2/17/22
Nindrea RD, Djanas D, Warsiti, et al. | Clin Epidemiol Glob Health
Aim: To determine the risk factors and pregnant women's desire to get the SARS-CoV-2 vaccine in various countries.
INFECTION CONTROL
2/17/22
Harwood R, Yan H, Talawila Da Camara N, et al.  | EClinicalMedicine
Aim: To identify which CYP were at increased risk of severe disease or death in CYP admitted to hospital with SARS-CoV-2 infection or PIMS-TS / MIS-C.
CLINICAL CHARACTERISTICS
2/16/22
Christensen RE, Jafferany M | JAAD Int
Aim: To investigate the association between new-onset alopecia areata or the exacerbation of pre-existing alopecia areata following infection with SARS-CoV-2.
CANDIDATE THERAPEUTICS
2/16/22
Schmidbauer ML, Ferse C, Salih F, et al.  | J Clin Med
Aim: To systematically investigate incidence, mortality, radiological subtypes and clinical characteristics of ICH in COVID-19 patients.
UPDATED
2/16/22
Barzegar M, Mirmosayyeb O, Ebrahimi N, et al. | Mult Scler Relat Disord
Aim: To assess the risk of coronavirus disease (COVID-19), clinical features and outcome among patients with neuromyelitis optica spectrum disorder (NMOSD).
CLINICAL CHARACTERISTICS
2/16/22
Shah K, Varna VP, Sharma U, et al. | QJM
Aim: To study the effect of vitamin D supplementation on morbidity and mortality in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
2/16/22
Veazie S, LaFavor B, Vela K, et al.  | J Affect Disord Rep
Aim: To compare the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assess whether the prevalence of mental health disorders varies by patient and disease characteristics, and ascertain mental health care utilization and resource needs for adults following hospitalization for COVID-19.
VA ESP
MENTAL HEALTH
2/16/22
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding post-acute and subacute care for COVID-19 patients.
UPDATED
2/16/22
Slusarska B, Nowicki GJ, Niedorys-Karczmarczyk B, et al. | Int J Environ Res Public Health
Aim: To establish and estimate the combined incidence of depression and anxiety among nurses during the COVID-19 pandemic using standard measurement tools.
MENTAL HEALTH
2/16/22
Yeun YR, Kim SD | Int J Environ Res Public Health
Aim: To explore the psychological effects of online-based mindfulness programs during the COVID-19 pandemic.
2/16/22
Schiavetti I, Ponzano M, Signori A, et al. | Mult Scler Relat Disord
Aim: To estimate the mortality rate among patients under anti-CD-20 therapies.
MENTAL HEALTH
2/16/22
Rezaei S, Hoseinipalangi Z, Rafiei S, et al. | J Affect Disord Rep
Aim: To examine the prevalence of depression and the impact of various factors among hospital staff with a view to organize related programs for reducing the complications of these disorders.
UPDATED
MENTAL HEALTH
2/15/22
Clark SE, Chisnall G, Vindrola-Padros C | EClinicalMedicine
Aim: To identify the supportive and operational strategies used for the flexible de-escalation of ICUs in the context of COVID-19.
UPDATED
2/15/22
Elberry MH, Abdelgawad HAH, Hamdallah A, et al. | J Thromb Thrombolysis
Aim: To report susceptible demographics outcomes, commonalities, and prognosis of reporting cases. 
CLINICAL CHARACTERISTICS
2/15/22
Tu J, Mo X, Zhang X, et al. | Expert Rev Respir Med
Aim: To assess the efficacy and safety of corticosteroids in COVID-19 patients compared with standard care or placebo.
UPDATED
CANDIDATE THERAPEUTICS
2/15/22
S?omka A, Kowalewski M, ?ekanowska E | Thromb Haemost
Aim: To assess the performance of TEG and TEM in the assessment of blood coagulation and fibrinolysis in patients with COVID-19.
2/15/22
Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, et al. | Blood Adv
Aim: To systematically review the clinical features and outcomes of patients with COVID-19 with confirmed HIT.
UPDATED
CLINICAL CHARACTERISTICS
2/15/22
Mehrabi Nejad MM, Moosaie F, Dehghanbanadaki H, et al. | Eur J Med Res
Aim: To evaluate the efficacy of COVID-19 mRNA vaccines in IC patients.
INFECTION CONTROL
2/15/22
 | Stomatologija
Aim: To describe the clinical characteristics of oral lesions in patients with COVID-19.
INFECTION CONTROL
2/15/22
Kunstler B, Newton S, Hill H, et al. | Infect Dis Health
Aim: To examine the differences in likelihood of SARS-CoV-2 infection and AEs between HCWs using respirators and surgical masks.
INFECTION CONTROL
2/15/22
Norhayati MN, Che Yusof R, Azman YM | Front Med
Aim: To estimate the pooled proportion of COVID-19 vaccine acceptance worldwide.
UPDATED
INFECTION CONTROL
2/15/22
Zhang X, Shang L, Fan G, et al. | Front Med
Aim: To provide a comprehensive summary of current evidence for a better understanding of the efficacy and safety of JAK inhibitors for COVID-19.
CANDIDATE THERAPEUTICS
2/14/22
Nguyen NN, Hoang VT, Dao TL, et al. | Eur J Clin Microbiol Infect Dis
Aim: To describe the burden of the long-term persistence of clinical symptoms in COVID-19 patients.
LONG COVID
2/14/22
Yang P, Wang J, Zheng R, et al. | Heart Lung
Aim: To evaluate the clinical improvement and mortality risk of convalescent plasma treatment in patients with severe and critically ill COVID-19 patients.
CANDIDATE THERAPEUTICS
2/14/22
Xiao D, Tang F, Chen L, et al. | Front Cardiovasc Med
Aim: To evaluate the association between thrombosis and the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
2/14/22
Kariyawasam RM, Dingle TC, Kula BE, et al. | Clin Microbiol Infect
Aim: To review the prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) and compare research definitions.
CLINICAL CHARACTERISTICS
2/14/22
Koritala T, Pattan V, Tirupathi R, et al. | Infez Med
Aim: To summarize infection risk of IL inhibitors, with or without the use of corticosteroids, used to treat hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
2/14/22
Ao G, Li J, Yuan Y, et al. | Nutr Clin Pract
Aim: To compare the disease severity and mortality in patients with COVID-19 who promptly received IV-VC treatment vs those who did not. 
CANDIDATE THERAPEUTICS
2/14/22
Bachour Y, Bekkenk MW, Rustemeyer T, et al. | J Cosmet Dermatol
Aim: To review the evidence on late inflammatory reactions in patients with soft tissue fillers after infection with SARS-CoV-2 and vaccination.
CLINICAL CHARACTERISTICS
2/14/22
Nagalli S, Kikkeri NS | Infez Med
Aim: To study the patient’s characteristics, risk factors, complications, and outcomes of COVID-19 patients diagnosed with mucormycosis.
CLINICAL CHARACTERISTICS
2/14/22
Alali AH, Smaisem MS, Alsheikh AM, et al. | Infez Med
Aim: To explore myocardial injury in coronavirus disease-19 (COVID-19) patients who were hospitalized with severe complicated infections.
CLINICAL CHARACTERISTICS
2/14/22
Dilokthornsakul W, Kosiyaporn R, Wuttipongwaragon R, et al. | J Integr Med
Aim: To review the mechanisms of propolis and honey against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and current evidence for the use of propolis and honey in COVID-19 prevention and treatment.
CANDIDATE THERAPEUTICS
2/14/22
Hosen I, Al-Mamun F, Mamun MA | Glob Ment Health
Aim: To review the Bangladeshi literature related to common mental health problems (i.e. depression, anxiety, and stress) during the COVID-19 pandemic.
MENTAL HEALTH
2/14/22
Zarghami A, Hussain MA, Campbell JA, et al. | Mult Scler Relat Disord
Aim: To conduct a rapid systematic review of the existing evidence on impact of the COVID-19 pandemic on mental health outcomes among PwMS.
MENTAL HEALTH
2/11/22
Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, et al. | Rev Neurosci
Aim: To describe the prevalence and risk of ACVE in patients with severe and nonsevere COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
Pischel L, Patel KM, Goshua G, et al. | Clin Infect Dis
Aim: To explore the potential associations of adenovirus-based vaccine components with symptoms of TTS in the general clinical trial population and in pregnant women in clinical trials.
INFECTION CONTROL
2/11/22
da Silva CGL, Santana JRP, Pinheiro LFG, et al. | Adv Exp Med Biol
Aim: To analyze the main morphofunctional changes in the involvement of multiple organs in patients infected with SARS-CoV-2, correlating anatomopathological findings with the clinical picture.
CLINICAL CHARACTERISTICS
2/11/22
Ramandi A, Akbarzadeh MA, Khaheshi I, et al. | Curr Probl Cardiol
Aim: To review articles inclusive of aortic dissection concurrent with Covid-19 infection.
CLINICAL CHARACTERISTICS
2/11/22
Jaiswal V, Nepal G, Dijamco P, et al. | J Prim Care Community Health
Aim: To systematically review the baseline features, clinical characteristics, treatment, and outcomes in patients developing CVST post-COVID-19 vaccination.
CLINICAL CHARACTERISTICS
2/11/22
Sharif PM, Nematizadeh M, Saghazadeh M, et al. | Pol J Radiol
Aim: To summarize the available data regarding chest CT features in confirmed cases of COVID-19.
DIAGNOSTICS
2/11/22
 | NSW Health COVID-19 Critical Intelligence Unit
2/11/22
Dettmann LM, Adams S, Taylor G | Br J Clin Psychol
Aim: To determine the prevalence of anxiety and depression during the first UK COVID-19 lockdown.
UPDATED
MENTAL HEALTH
2/11/22
 | NSW Health COVID-19 Critical Intelligence Unit
2/11/22
Jahn R, Hintermeier M, Bozorgmehr K | J Migr Health
Aim: To quantify the attack rate of SARS-CoV-2 during outbreaks among refugees living in reception and accommodation centres in Germany.
INFECTION CONTROL
2/11/22
Avallone G, Quaglino P, Cavallo F, et al.  | Int J Dermatol
Aim: To provide an extensive overview of all the vaccine-related cutaneous manifestations reported in the literature thus far.
INFECTION CONTROL
2/11/22
 | NSW Health COVID-19 Critical Intelligence Unit
2/11/22
Liu N, Yang D, Zhang T, et al. | Int J Infect Dis
Aim: To assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
Hsu CK, Chen CY, Chen WC, et al. | Int J Antimicrob Agents
Aim: To assess the impact of sofosbuvir-based treatment on the mortality of patients with COVID-19.
CANDIDATE THERAPEUTICS
2/11/22
Al Kiyumi MH, Kalra S, Davies JS, Kalhan A | Indian J Endocrinol Metab
Aim: To ascertain the prevalence of VDD in patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
Ji Y, Fang Y, Cheng B, et al. | Crit Care
Aim: To systematically appraise the existing COVID-19 studies examining the impact of ET on the primary outcomes of duration of IMV, duration of ICU stay, and overall reported mortality and secondary outcomes of ventilator-associated pneumonia (VAP), time from tracheostomy to ventilator weaning, and duration of sedation.
CANDIDATE THERAPEUTICS
2/11/22
Tanni SE, Silvinato A, Floriano I, et al. | J Bras Pneumol
Aim: To answer questions related to the use of remdesivir for the treatment of patients hospitalized with moderate to severe COVID-19.
CANDIDATE THERAPEUTICS
2/9/22
Audrey J, Wisnu W, Tahapary DL | Curr Diabetes Rev
Aim: To investigate the association between statin use and poor outcomes in COVID-19 patients with diabetes.
CLINICAL CHARACTERISTICS
2/9/22
Bhatt A, Bumbrah GS, Ruwali M, et al. | Pathog Glob Health
Aim: To assess the diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technology.
DIAGNOSTICS
2/9/22
Cuninghame S, Gorsky K, Francoeur C, et al. | BMJ Open
Aim: To summarise the known effects of inhaled sedatives on cognitive and psychiatric outcomes.
2/9/22
Han S, Zhuang Q, Chiang J, et al. | BMJ Open
Aim: To determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA).
CLINICAL CHARACTERISTICS
2/9/22
Al-Maiahy TJ, Al-Kuraishy HM, Al-Gareeb AI | J Pak Med Assoc
Aim: To illustrate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during pregnancy and to explore pregnancy outcomes, vertical and perinatal transmission as well as management of coronavirus disease-2019 (Covid-19) during pregnancy.
CLINICAL CHARACTERISTICS
2/9/22
Brown C, Wilkins K, Craig-Neil A, et al. | Public Health Rev
Aim: To identify the areas of greatest concern and synthesize recommendations to support a more equitable pandemic response.
2/9/22
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis | J Korean Med Sci
Aim: To identify children at high risk of severe COVID-19, with a focus on comorbidities and age.
CLINICAL CHARACTERISTICS
2/9/22
Jahrami HA, Alhaj OA, Humood AM, et al. | Sleep Med Rev
Aim: To evaluate the extent of sleep disturbances during the COVID-19 pandemic.
UPDATED
2/9/22
Boppana TK, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim: To estimate the effectiveness of tocilizumab in reduction of mortality due to COVID-19. 
CANDIDATE THERAPEUTICS
2/8/22
Mendoza JPIM, Ubillús BPT, Bolívar GTS, et al. | Saudi Dent J
Aim: To evaluate the antiviral effect of mouthwashes against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
UPDATED
2/8/22
Abas?yan?k Z, Kurt M, Kahraman T | J Dev Phys Disabil
Aim: To investigate the physical activity changes in people with neurological diseases, and to examine the relationship between physical activity and disease symptoms, and psychosocial factors. 
UPDATED
2/8/22
Carrara E, Ong DSY, Hussein K, et al.  | Clin Microbiol Infect
Aim: To address the indications for direct testing of SARS-CoV-2 in asymptomatic individuals in healthcare facilities with the aim to prevent SARS-CoV-2 transmissions in these settings.
INFECTION CONTROL
2/8/22
Shi S, Wang F, Yao H, et al.  | Front Med
Aim: To evaluate the potential effect of CHM on immune related profile compared with routine treatment during COVID-19, and to investigate whether the clinical parameters were improved through the immunity profile based on randomized controlled trials (RCTs).
UPDATED
CANDIDATE THERAPEUTICS
2/8/22
Alkodaymi MS, Omrani OA, Fawzy NA, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods.
CLINICAL CHARACTERISTICS
2/8/22
Budi DS, Pratama NR, Wafa IA, et al. | Heliyon
Aim: To critically evaluate and summarize the latest evidence of remdesivir for COVID-19 in terms of its efficacy and safety profile among pregnant women.
UPDATED
CANDIDATE THERAPEUTICS
2/8/22
Sakuraba A, Luna A, Micic D | J Hematol Oncol
Aim: To assess the serologic response to COVID-19 vaccination in patients with cancer.
INFECTION CONTROL
2/8/22
Wang Y, Zhu K, Dai R, et al. | Front Pharmacol
Aim: To evaluate the efficacy and safety of specific interleukin (IL)-1 inhibitors, specific IL-6 inhibitors, and GM-CSF blockades in the treatment of COVID-19 (at the edge of sepsis) patients.
UPDATED
CANDIDATE THERAPEUTICS
2/8/22
Soysal P, Smith L, Trott M, et al.  | Psychogeriatrics
Aim: To investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI.
MENTAL HEALTH
2/8/22
Baker J, Krishnan N, Abroms LC, et al. | J Smok Cessat
Aim: To determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
2/8/22
Tan Z, Huang S, Mei K, et al.  | Front Cardiovasc Med
Aim: To determine the prevalence and associated death of ventricular arrhythmia and sudden cardiac death (SCD) in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/7/22
Ganesh A, Randall MD | Br J Clin Pharmacol
Aim: To investigate the effects of metformin on outcomes in patients with COVID-19 and DM.
UPDATED
CANDIDATE THERAPEUTICS
2/7/22
Wu H, Dai R, Wu X, et al.  | Am J Chin Med
Aim: To evaluate the efficacy and safety of traditional Chinese medicine for COVID-19 treatment with a focus on the benefits of symptomatic relief and time-related indexes.
CANDIDATE THERAPEUTICS
2/7/22
Schietzel S, Anderegg M, Limacher A, et al. | RMD Open
Aim: To review the evidence on SARS-CoV-2 vaccine induced humoral and cell-mediated immune response in patients previously treated with anti-CD20 antibodies.
INFECTION CONTROL
2/7/22
Premraj L, Kannapadi NV, Briggs J, et al. | J Neruol Sci
Aim: To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.
CLINICAL CHARACTERISTICS
2/7/22
Safi-Keykaleh M, Aliakbari F, Safarpour H, et al. | Int J Gynaecol Obstet
Aim: To evaluate the prevalence of postpartum depression during COVID-19.
UPDATED
MENTAL HEALTH
2/7/22
Zhang H, Xie F, Yang B, et al. | Am J Infect Control
Aim: To explore the experience of COVID-19 patients.
UPDATED
MENTAL HEALTH
2/7/22
Duarsa MDVI, Kandarini Y, Yogiswara N, et al. | Truk J Urol
Aim: To systematically review the current findings regarding survival and clinical outcomes of KT recipients with COVID-19 infection.
CLINICAL CHARACTERISTICS
2/7/22
Aldukhayel A | Endokrynol Pol
Aim: To synthesize evidence on the impact of the COVID-19 lockdown on the glycaemic control, physical activity, and diet of diabetic patients.
2/7/22
Mohammed I, Nauman A, Paul P, et al.  | Hum Vaccin Immunother
Aim: To compare the efficacy and effectiveness of seven COVID-19 vaccines.
INFECTION CONTROL
2/7/22
Petrelli F, Luciani A, Borgonovo K, et al. | J Med Virol
Aim: To review the evidence on the efficacy and safety of a third dose of COVID-19 vaccine in various general population settings.
INFECTION CONTROL
2/7/22
Shi N, Huang J, Ai J, et al.  | J Infect Public Health
Aim: To review the evidence on the transmissibility and pathogenicity of COVID-19.
INFECTION CONTROL
2/4/22
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize their clinical features, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
2/4/22
Chu CW, Jiesisibieke ZL, Yang YP, et al. | Expert Rev Vaccines
Aim: To review the evidence on the association between herpes zoster and COVID-19 vaccinations.
INFECTION CONTROL
2/4/22
Malik J, Zaidi SMJ, Waqar AU, et al. | Expert Rev Endocrinol Metab
Aim: To assess the prevalence of hypothyroidism in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Chutiyami M, Cheong AMY, Salihu D, et al. | Front Psychiatry
Aim: To provide a comprehensive overview of overall mental health of healthcare professionals during the COVID-19 pandemic.
MENTAL HEALTH
2/4/22
Ergün A, Bekar A, Aras B, et al. | Turk Thorac J
Aim: To survey how vaccine hesitancy is addressed in the PubMed articles about "vaccine hesitancy" over the novel coronavirus disease and to understand their recommendations for the prevention of vaccine hesitancy.
INFECTION CONTROL
2/4/22
Patoulias D, Doumas M | Endocrinol Metab
Aim: To review the evidence from observational studies addressing the risk of COVID-19 death among patients with type 2 diabetes mellitus on prior DPP-4 inhibitor treatment.
CANDIDATE THERAPEUTICS
2/4/22
Mir T, Attique HB, Sattar Y, et al.  | Cardiovasc Revasc Med
Aim: To evaluate the mortality outcomes of critically ill patients with and without PE (WPE).
CLINICAL CHARACTERISTICS
2/4/22
Rincón Uribe FA, Godinho RCS, Machado MAS, et al.  | PLoS One
Aim: To offer a rapid synthesis of the evidence about effect of health knowledge, as broader measure that includes detailed and objective information on health components, to adopt health behaviors and attitudes during pandemics.
INFECTION CONTROL
2/4/22
Rivera PA, Nys BL, Fiestas F | Medwave
Aim: To investigate the impact of COVID-19-induced lockdowns on university student physical activity and sedentary behav-ior, as these relate to physical and mental well-being.
MENTAL HEALTH
2/4/22
Pratama NR, Wafa IA, Budi DS, et al. | PLoS One
Aim: To review the latest evidence on Covid-19 vaccination to summarize its efficacy, immunogenicity, and safety profile in pregnant women.
INFECTION CONTROL
2/4/22
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate the pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS).
CLINICAL CHARACTERISTICS
2/4/22
Ouyang L, Gong J, Yu M | Int Immunopharmacol
Aim: To investigate the prevalence of ILD among patients with COVID-19 and figure out the relationship between ILD and the poor clinical outcomes of COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Norhayati MN, Che Yusof R, Azman MY | Int J Environ Res Public Health
Aim: To ascertain the prevalence of psychological impacts among healthcare providers in the Asian region.
UPDATED
MENTAL HEALTH
2/4/22
Prada L, D Santos C, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
CLINICAL CHARACTERISTICS
2/4/22
Montero-Vilchez T, Cuenca-Barrales C, Martinez-Lopez A, et al. | J Eur Acad Dermatol Venereol
Aim: To summarize the prevalence, type and risk factors for cutaneous adverse events related to PPE and prevention measures to avoid them.
INFECTION CONTROL
2/4/22
Schmidt RA, Genois R, Jin J, et al. | Drug Alcohol Depend
Aim: To examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems.
UPDATED
MENTAL HEALTH